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Steroid and eicosanoid metabolism occurs in two phases and primarily within
hepatic tissues, but localized metabolism has been examined in several extra-hepatic
tissues in humans and rodents. Phase I of metabolism is performed by Cytochrome P450s
(CYP) that add hydroxyl groups to the carbon ring structure which is further metabolized
by phase II UDP-glucuronosyltransferase (UGT). The overall objectives of the following
experiments were to: 1) determine the amount of extra-hepatic steroid metabolism within
reproductive tissues of cattle across the estrous cycle; 2) determine the amount of extrahepatic steroid metabolism and an oxylipin profile within reproductive tissues of cattle
based on pregnancy status; and 3) determine the amount of endometrial blood perfusion
in cattle using a novel laser Doppler technique. Activity of CYP1A was found within
corpora lutea (CL) tissues of both pregnant and non-pregnant cattle, but not within
endometrial tissues. Endometrial perfusion, measured using a novel laser Doppler
technique, was also validated by measuring angiogenic factors in close proximity to the
location of perfusion. A positive correlation (r = 0.28; P = 0.04) was observed between
endometrial perfusion and nitrite concentration, an angiogenic factor. Endometrial blood

perfusion was affected by the proximity to the CL, but not by the proximity of the
dominant follicle. In addition, UGT was categorized across the estrous cycle and the
activity was dependent upon the proximity of the CL. Oxylipins, including eicosanoids,
were also profiled in CL of cattle that were non-pregnant and pregnant with 5 out of 39
oxylipins differentially expressed. The activity and oxylipin products of steroid and
eicosanoid enzymes were not correlated with serum or luteal progesterone. Through these
experiments, we have verified that there is localized metabolism of steroids and
eicosanoids within reproductive tissues of cattle as well as fetal tissues. Also, we have
achieved a full oxylipin profile of non-pregnant and pregnant cattle CL with five
oxylipins contained in various amounts between pregnancy status.
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CHAPTER I
REVIEW OF LITERATURE
The Estrous Cycle
The estrous cycle consists of two primary phases, the follicular phase and luteal
phase. The follicular phase, corresponds to a decrease in progesterone (P4) from the
regressing corpus luteum (CL) and an increase in estrogens, especially estradiol-17β (E2)
from the developing follicle (Fortune et al., 1988). The follicular phase ends with the
ovulation of a dominant follicle. The ovulated follicle will then transition from a corpus
hemorraghicum to a CL, which initiates the start of the luteal phase. If a successful
pregnancy is not established by a competent conceptus, the CL will regress and the cycle
will repeat every 21 days, on average, in cattle, pigs, and horses, while in sheep the cycle
will repeat every 17 days (Henricks et al., 1972; Nett et al., 1976; Baird, 1978; Ginther et
al., 1989). One important concept during normal reproductive cyclicity is the cross talk
between ovarian and uterine secretions during the follicular and luteal phases of the
estrous cycle (Kimmins and Maclaren, 2001). Transplanting ovaries from adjacent to the
uterus to the neck of cyclic ewes determined that the prostaglandin F2α (PGF2α) secreted
from the uterus affected the ovarian structure, the CL, to cause luteolysis (McCracken et
al., 1999). This insured that there were substances coming from the uterus to act upon the
ovaries. During the follicular phase, increased secretion of E2 from the dominant follicle
on the ovary is transferred in the blood and acts upon several tissues including the uterus.
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Estrogen exposure to the uterus results in increased blood flow, increased smooth muscle
motility, and growth and development of uterine glands of the endometrium (Ford, 1982).
Similarly, during the luteal phase, increased secretion of P4 from the CL on the
ovary is transferred in the blood and acts upon several tissues including the uterus.
Exposure of P4 to the uterus results in a blockage of smooth muscle contractions of the
uterus and stimulates nutritive secretions from the uterine glands of the endometrium
(Nephew et al., 1994). The luteal phase ends with uterine secretion of the hormone
PGF2α, which regresses the functional CL, allowing for emergence of the next follicular
phase (Shemesh and Hansel, 1975). Uterine secretion of PGF2α is partially initiated by
down-regulation of uterine P4 receptors followed by up-regulation of uterine estrogen
receptors (ER) and oxytocin receptors (OTR) as well as a major enzyme involved in
prostaglandin synthesis, cyclooxygenase. Irrespective of the exact mechanisms, ovarian
steroid secretion, and uterine exposure contributes to normal reproductive cyclicity in
cattle. Moreover, these same pathways are also involved in establishing a successful
pregnancy.
Pregnancy
Maternal Recognition of Pregnancy
Maternal recognition of pregnancy occurs between d 15 and 17 in cattle, which
prolongs the lifespan of the CL. Within ruminant animals, the conceptus secretes
interferon-tau (IFNτ), which suppresses the expression of the OTR, stimulating the
synthesis of COX-2 within the endometrium. Production of IFNτ reaches its peak at
approximately d 15 in sheep (Ashworth and Bazer, 1989) and d 17 in cattle (Demmers et
al., 2001). This disallows the pulsatile release of PGF2α within the endometrium, and
2

secretes pro-embryonic proteins, which results in a hospitable uterine environment
(Bazer, 1992; Cheng et al., 2007). Tight junctions are reduced within the uteri of sheep
on day 12 of the estrous cycle, which could allow for small molecules to permeate the
endometrium and facilitate the transport of IFNτ. The trophectoderm cells of the fetus
secrete IFNτ, which signals the CL to not undergo luteolysis (Roberts et al., 1990;
Spencer et al., 1996; Imakawa et al., 2009; Bazer et al., 2010). In cattle, at d 16 of their
estrous cycle, the lack of a conceptus allows for expression of the OTR, production of
oxytocin (OT) by the CL, inducing COX-2 to increase the synthesis of prostaglandin
intermediates, and stimulates the activity of prostaglandin F synthase, which is a vital
enzyme of PGF2α synthesis (Kim et al., 2003) within the endometrium and results in an
embryo-toxic uterine environment (Bazer, 1992; Cheng et al., 2007; Figure 1).
Placenta
The placentas of livestock species are categorized into two different
morphological groups. Cotyledonary placentas are within ruminant species and have
synepitheliochorial microscopic anatomy. Diffuse placentas are within horses and pigs
and has a the microscopic anatomy is epitheliochorial placenta (Moll and Kunzel, 1973;
Nakaya and Miyazawa, 2015). Cotyledonary placentas only attach at portions of the
uterine wall that protrude called caruncles and the fetal attachment portions that are
complementary to these caruncles are called cotyledons (Moll and Kunzel, 1973; Lemley
et al., 2012; Nakaya and Miyazawa, 2015). Similar to gestation length, birth weight, and
estrous cycle length, placental morphometric measurements are highly dependent on
breed within a certain species and are highly dependent on maternal breed and parity
(Bienson et al., 1999; Ford et al., 2002).
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Placentation is the period of maternal and fetal portions of the placenta attaching
cand growing together and developing (Wilson, 2002). In ewes, placental attachment
begins at approximately d 15 of gestation (Flint et al., 1979). By d 20 of pregnancy in
ewes, the conceptus is adhered to the uterine wall and placentation occurs through about
d 45 of pregnancy. Placental length increases to about 30 cm between d 25 and 140 of
gestation, whereas, total placental weight increases between d 25 and 80 of gestation and
remains rather constant thereafter in sheep (Bazer et al., 2011). Placental attachment in
cattle, however, does not begin until around d 22 of gestation in cattle (Amoroso, 1959).
During d 40 to 70, organ differentiation begins, bone ossification, and formation and
completion of orientation and stomach compartments occurs (Caleb O. Lemley et al.,
2014). By d 150 of gestation caruncular and cotyledonary vascularization is complete and
growth of the placenta increases 2-fold from d 150 to 250 of gestation, while fetal weight
significantly increased by 15-fold from d 150 to 250 of gestation (Reynolds and Redmer,
1995).
Steroid Hormones
Introduction and Synthesis
Steroid hormones are highly lipophilic and have a 4-ring nucleus that comes from
the base structure of cholesterol. Synthesis of steroid hormones can be facilitated by
almost every cell type within the body. This process begins with the movement of
cholesterol, into the inner mitochondrial membrane by steroidogenic acute regulatory
protein (StAR). This cyclic-AMP-dependent phosphoprotein (Kohen et al., 2003) is
thought to be the rate limiting step of steroid synthesis and has a half-life of about 4 min.
(Juengel et al., 2000). Once the cholesterol is within the inner mitochondrial membrane
4

cytochrome P450 (CYP) side-chain cleavage (CYP11A1) cleaves the aliphatic side chain
between carbon 20 and 22, then oxidizes the 20 carbon to yield a ketone group at the 17
carbon (Payne and Hales, 2004). This newly formed molecule, termed pregnenalone, has
21 carbons and can be further metabolized into various steroid hormones. For the
synthesis of P4, pregnenalone is moved into the smooth endoplasmic reticulum where 3
beta-hydroxysteroid dehydrogenase (3β-HSD) converts it into P4 (Payne and Hales,
2004). This conversion of pregnenalone to P4 is highly dependent upon product inhibition
(Caffrey et al., 1979). Greater concentrations of P4 means that there will be less P4
produced. Progesterone can be further converted to 17α-hydroxyprogesterone, a fellow
progestagen, via 17α-hydroxylase (CYP17) within the smooth endoplasmic reticulum
(Payne and Hales, 2004). 17α-hydroxyprogesterone will then lose 2 carbons and become
a part of the androgen class, specifically androstenedione, by 17, 20 lyase (Morato et al.,
1961; Akhtar et al., 2011). Androstenedione can be further converted into other
androgens via 17 beta-hydroxysteroid dehydrogenase to yield testosterone and further
converted into dihydrotestosterone by 5α-reductase (Payne and Hales, 2004). However,
androstenedione and testosterone can also be converted into various types of estrogens
via aromatase to yield estrone and estradiol, respectively (Weisz and Gibbs, 1974;
Sherman and Korenman, 1975).
Corpus Luteum
The LH surge immediately prior to ovulation induces the luteinization of
granulosal and thecal cells (Juengel et al., 1995; Niswender et al., 2000). This
luteinization process alters the steroidogenic pathway which helps ensure that P4 is the
primary steroid hormone produced (Juengel et al., 1995; Niswender et al., 2000; Scully et
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al., 2015). However, several species including humans, pigs, and rats, maintain the ability
to produce a large amount of E2 by the CL (Niswender et al., 2000). As the CL
progresses through maturation, from early to mid to mid-late luteal phase, the large luteal
cells undergo hypertrophy, increase in cellular size, whereas the small luteal cells will
undergo hyperplasia, increase in cell numbers (Meidan et al., 1990). While the small
luteal cells produce a smaller amount of P4, the large luteal cells produce the greater
quantity of P4 to be secreted into circulation (Rodgers and O’Shea, 1982).
The developing CL has a large amount of angiogenesis and has one of the largest
blood flows per gram of tissue (Herzog et al., 2010; Shirasuna, 2010). Blood flow in CL
from beef heifers was not different between d 7 and 14 comparing non-pregnant and
pregnant CL; however, d 14 to 18, non-pregnant CL decreased in blood flow, whereas
pregnant CL maintained a constant amount of blood flow (Scully et al., 2015). This
decrease in blood flow of the CL is due to the anti-luteotrophic effects of PGF2α that is
secreted at d 15 of the estrous cycle and begins the functional and structural regression of
the CL (Scully et al., 2015). Concentrations of mRNA encoding for StAR decreased
rapidly which affected downstream steroidogenic enzymes, 3β-HSD, and CYP11A1, 9 hr
after administration of PGF2α within CL tissues of ewes (Juengel et al., 2000). The
maintenance of blood flow after d 15 in pregnant animals was due to the secretion of
IFNτ by the trophectoderm cells, which is luteotrophic and maintains the physiological
and structural integrity of the CL in order to maintain the pregnancy (Roberts et al., 1990;
Spencer et al., 2008; Scully et al., 2015). As outlined in Figure 1, IFNτ induces the
production of COX-2 resulting in the secretion of PGE2, which increases the amount of
cyclic AMP and increases angiogenesis of the endometrium (Cheng et al., 2007).
6

Progesterone
Progesterone is a steroid hormone with 21 carbons, and has been noted to create a
type of quiescence of the uterus which minimizes the myometrial contractions and affects
the movement of blood through capillary beds within the endometrium (Grazzini et al.,
1998; Soloff et al., 2011). The primary source of P4 is the transient organ, the CL, which
is present on an ovary post-ovulation. However, the adrenal gland was observed to
secrete as much P4 in stressed rats as compared to the amount of P4 secreted from the
ovary while the rat was in the metestrus phase (Fajer et al., 1971). Once ovulation occurs
the cells within the ovulation site begin to differentiate where the granulosal cells become
large luteal cells and the theca interna cells become small luteal cells (Milvae et al.,
1996). The stimulation for P4 production is due to the binding of luteinizing hormone
(LH) from the gonadotropin cells of the anterior pituitary (Dehejia et al., 1982; Milvae et
al., 1996) to the LH receptors. These LH receptors can be induced to degrade and
internalize at a slower rate with the supplementation of LH-like substances, such as
human chorionic gonadotropin (hCG). Mock and Niswender (1983) observed that
internalization and degradation by luteal cells are greatly extended in sheep with
radiolabeled hCG, 22.8 ± 2.3 hr, when compared to natural sheep LH, 0.4 ± 0.2 hr. The
increased half-life of hCG is due to the increased glycosylation which prevents proteases
from degrading the molecule (Kessler et al., 1979).
Cyclooxygenase (COX)
The cyclooxygenase (COX) pathway includes the generation of prostaglandins,
resolvins, and protectins (Calder, 2010). Cyclooxygenase acts through two different
isoforms cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2), which can be
7

activated ubiquitously (Inskeep, 1973; Funk, 2001). Actions of COX-1 include renal
electrolyte and water homeostasis, cytoprotection of gastric cells, and activation of platelet
aggregation and clot formation. While COX-2 is primarily responsible for the metabolism
of arachidonic acid into various prostaglandin species (Funk and Powell, 1983; Funk, 2001;
Arosh et al., 2004; Shishodia et al., 2004). This pathway begins with arachidonic acid
which is then converted to PGG2 by COX-2, which is then converted to PGH2 by
prostaglandin endoperoxidase H2 synthase, where it can be converted into various
prostaglandins with their respective synthase enzymes.
The amount of arachidonic acid can vary within an animal based on their nutritional
availabilities. Certain fatty acids are more readily converted into arachidonic acid and
therefore converted into prostaglandins (Herrera-Camacho et al., 2011). Expression of
COX-2 has primarily been found in the luminal and superficial glandular epithelial cells
(Kim et al., 2003), which coincides with the secretion of PGF2α into the uterine lumen.
These prostaglandins include prostaglandin E2 (PGE2) which is angiogenic, as well as
PGF2α which is known to be embryo-toxic (Canby-Hagino and Thompson, 2005; Figure
2).
Expression of COX isoforms are dependent upon the pregnancy status of the host
animal. Cycling cows and ewes yielded an increase in COX-2 mRNA in endometrial
tissue from the mid- to late-luteal portion of the estrous cycle (Kim et al., 2003; Arosh et
al., 2004), and expression of COX-2 in bovine endometrium is over 4 fold greater than
COX-1 (Emond et al., 2004). Staining intensity for COX-2 increased in cattle epithelial
stroma tissue, ipsilateral to the CL as compared to contralateral to the CL, at day 16 when
the uterus is infused with IFNτ (Emond et al., 2004). Pregnant ewes resulted in greater
8

COX-2 mRNA than cycling ewes beginning on d 12 through d 16 (Kim et al., 2003), and
fetal tissues at d 18 of pregnancy expressed COX-2 mRNA and protein (Kim et al.,
2003).
Lipoxygenase (LOX)
The lipoxygenase (LOX) pathway primarily produces leukotrienes, resolvins, and
protectins (Calder, 2010). Lipoxygenases are iron dioxygenases that specifically insert
oxygen into polyunsaturated fatty acids, resulting in the formation of hydroxyeicosatetraenoic acid (HETE) molecules (Funk, 2001). Leukotrienes are made
predominately by inflammatory cells in response to activation of immune complexes.
Resolvins and protectins have been noted to inhibit migration of neutrophils which in
turn minimizes the inflammatory response elements (tumor necrosis factor α - TNFα,
interleukins, and necrosis factor- κB - NF-κB) and thereby act as anti-inflammatory
(Calder, 2010). Administration of PGF2α increased T cell proliferation in regressing
luteal cells (Davis and Pate, 2007). Leukocytes are recruited to the CL throughout its
lifespan to either encourage chemokine mediators, during luteolysis, and recruitment of
antiapoptotic molecules to potentiate survival (Pate et al., 2010). Products of enzymatic
activity of LOX, including several HETE, are greater in amniotic fluid of women that
were in labor as compared to women that were not (Romero et al., 1987). However,
immediately prior to labor, leukotrienes were in greater amounts as compared to HETE
(Mitchell and Grzyboski, 1987).
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Oxylipins
Oxylipins are a family of lipids that result from biosynthesizing polyunsaturated
fatty acids (PUFA) which result in products such as eicosanoids, epoxides, diols,
thromboxanes, and leukotrienes (Calder, 2010; Gouveia-Figueira et al., 2015; Mavangira
and Sordillo, 2017). Eicosanoids are derived from arachidonic acid by the COX-2
pathway as described above and outlined in Figure 2. These eicosanoids cannot be stored,
which indicates that they are to be formed de novo when cells are mechanically or
chemotoxically challenged by any cell within the body (Funk, 2001). Metabolism of
omega fatty acids into oxylipins occurs via CYP, COX, and LOX enzymes and further
metabolism by UGT to inactivate these oxylipins (Heemskerk et al., 2014). Metabolites
of CYP are classified as dihydroxyoctadecenoic acid (HOME) and
dihydroxyeicosatrienoic acid (HODE), metabolites of COX enzymes are classified as
prostaglandins (PG) and thromboxanes (TX), and metabolites of LOX enzymes are
classified as HETE and octadecadienoic acids (ODE; Calder, 2010; Chang et al., 2012;
Bruins et al., 2013; Gouveia-Figueira and Nording, 2015a).
Some eicosanoids are important for the regression of the CL, such as PGF2α
(Rekawiecki et al., 2008), which allows for the non-pregnant female to begin another
follicular phase of the estrous cycle, but other eicosanoids are important for the
maintenance of the CL, such as PGE2, to prolong during gestation and produce P4
(Weems et al., 2011). Production of these oxylipins have been linked to inflammatory
responses (Calder, 2010; Zivkovic et al., 2012; Mavangira and Sordillo, 2017) and
increased intake of omega fatty acids (White et al., 2012; Gouveia-Figueira and Nording,
2015b; Mavangira and Sordillo, 2017). The ODE are specifically α-linoleic acid, linoleic,
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and oleic acid via LOX enzymes and have been identified in human serum and plasma,
hepatic, and intestinal microsomes (Little et al., 2004; Zivkovic et al., 2012; GouveiaFigueira et al., 2015; Berkecz et al., 2017). Supplementation of omega fatty acids have
decreased the inflammatory oxylipins (Zivkovic et al., 2012; Bruins et al., 2013),
increased density of omega 3 fatty acids in the blood (White et al., 2012), and increase in
ODE concentration which have been noted to be involved with cellular proliferation
(Reynolds et al., 2006). Several oxylipins are expressed in a sexually dimorphic manner.
In pigs, supplementation with arachidonic acid in the diet, increased 12,13-DiHOME in
females, but decreased 14,15-DiHETrE in females (Bruins et al., 2013).
Expression of epoxide hydrolase mRNA was greatest in macaque CL tissue
between mid-late and late luteal phase (Irusta et al., 2007). Epoxide hydrolase
metabolites, such as 9,10-DiHOME and 19,20-DiHDPE, have been differentially
expressed in the cow brain, heart, and liver, with the liver containing the greatest quantity
and the brain with the lesser (Gouveia-Figueira and Nording, 2015b). Supplementation of
human breast cancer cells with 19,20-DiHDPE decreased angiogenic factors and tumor
growth. Supplementation also decreased metastasis of lung cancer in rat lungs (Bruins et
al., 2013). These metabolites are potent vasodilators as compared to other categories of
oxylipins (Ulu et al., 2014). Production of these oxylipins has been linked to both proand anti-inflammatory responses (Calder, 2010; Zivkovic et al., 2012; Mavangira and
Sordillo, 2017) and increased intake of omega fatty acids (White et al., 2012; GouveiaFigueira and Nording, 2015b; Mavangira and Sordillo, 2017). Increased omega fatty
acids within the diet has increased these omega fatty acids within CL tissues and
concurrently increasing production of P4 in sheep (Abayasekara and Wathes, 1999).
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Metabolism of these omega fatty acids into oxylipins occurs via CYP enzymes and
further metabolism by UGT to inactivate these oxylipins (Heemskerk et al., 2014).
Specific CYP and UGT isoforms for these pathways are discussed in further detail below.
Phase I Steroid and Eicosanoid Metabolism
Cytochrome P450
Cytochrome P450 1A (CYP1A)
Cytochrome P450 1A (CYP1A) is involved in metabolizing and activating
polycyclic aromatic hydrocarbons, which includes steroid hormones, eicosanoids, fatty
acids, and xenobiotics (Chun et al., 1999). Expression of CYP1A has been observed in
the human lung, placenta, lymphocytes, and in low amounts in the liver. Oxidation of
estrone and estradiol to 2-hydroxyestradiol is performed by CYP1A in the human (Figure
3; Khan and Khan, 2013). The metabolite of CYP1A, 2-hydroxyestradiol, has been
observed to reduce angiogenesis, and the methylated metabolite of 2-hydroxyestradiol
produced by catechol-o-methyltransferase (2-methoxyestradiol) has exhibited proinflammatory and anti-angiogenic properties (Khan and Khan, 2013). Bovine fertilized
oocytes exposed to 2-methoxyestradiol decreased the development of d 2 and 4 early
morula in a dose dependent fashion; however, treatment with 2-methoxyestradiol on d 6
post-fertilization did not affect cellular replication and progression from the blastocyst
stage (Lattanzi et al., 2003).
Janele et al., (2006) observed a dose dependent increase in secretion of TNFα
when human male whole blood samples were stimulated with cortisol and E2, and when
they were stimulated with 2-hydroxyestradiol and 2-hydroxyestrone (CYP mediated
metabolites of estradiol and estrone, respectively). Our laboratory was the first to
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discover CYP activity in cultured bovine endometrial cells. Moreover, the activity of
CYP enzymes in these cells was decreased by treatment of IFNτ (Gilfeather and Lemley,
2016). Intra-liver activity of CYP1A was not affected throughout gestation of beef cows,
but activity of CYP1A was significantly decreased in those beef cattle that had been
nutrient restricted (60% of NRC requirements) compared to non-nutrient restricted cattle
beginning on d 30 of gestation until d 140 of gestation (Hart et al., 2014). In vivo uterine
expression and/or activity of CYP1A has not been examined to date.
Cytochrome P450 2C (CYP2C)
Metabolism and oxidation are primarily the role of CYP2C and focuses on
metabolizing P4, as outlined in Figure 3. Various tissues in monkeys were tested for the
expression of mRNA for CYP2C within the testis, small intestines, adrenal glands,
kidneys, uterus, and brain, with minimal amounts found; however, there was no presence
in the heart and lung, but there was a greater presence within the liver (Uno et al., 2006).
Cattle receiving a high fiber diet compared to cattle receiving a high corn starch diet were
also observed to have a significant increase in CYP2C activity in hepatic tissue, and
yielded a significant decrease in insulin in peripheral blood circulation (Lemley et al.,
2010). A recently discovered CYP2C (CYP2C44) in mice was found to convert
arachidonic acid into epoxyeicosatrienoic acids (EET; DeLozier et al., 2004). These EET
influence vasorelaxation as well as anti-inflammatory and pro-fibrinolytic effects in the
cardiovascular system (Roman, 2002). Also, DeLozier et al. (2004) found that CYP2C
was expressed more in female adrenal and kidney tissues compared with male kidney and
adrenal tissues. Intra-liver activity of CYP2C was not affected throughout gestation of
beef cows (Hart et al., 2014). Also, CYP2C activity was significantly decreased in those
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beef cattle that had been nutrient restricted (60% of NRC requirements) compared to nonnutrient restricted cattle beginning on d 30 of gestation until d 140 of gestation (Hart et
al., 2014). Expression of several isoforms of CYP2C were observed in CL tissue of
rhesus macaques and were more greatly expressed during the mid to late luteal phase
(Irusta et al., 2007). Uterine expression and/or activity of CYP2C has not been examined
to date. Finally, there were significant amounts of staining within the hepatocyte cells of
the mouse liver for CYP2C (DeLozier et al., 2004). Metabolism and epoxygenation of
PUFA are produced primarily by the isoforms of CYP2C to produce oxylipins
(Mavangira and Sordillo, 2017).
Cytochrome P450 3A (CYP3A)
Metabolism and oxidation are primarily the roles of CYP3A and focuses on
metabolizing P4 and E2, as outlined in Figure 3. Holstein cows yielded a greater rate of P4
clearance, indicated by the significant decrease in P4 half-life, in cattle receiving a high
fiber diet compared to cattle receiving a high corn starch diet (Lemley et al., 2010). These
Holstein cattle were also observed to tend to have an increase in CYP3A activity in
hepatic tissue (Lemley et al., 2010). Holstein cows, during late-lactation, treated with
1,000 IU of hCG did not increase activity of CYP3A in hepatic tissues even though blood
perfusion score was significantly greater in the CL between d 10 and 17 of the estrous
cycle of those treated cattle compared to the control cattle (Voelz et al., 2015). Hepatic
activity of CYP3A was significantly less on d 254 of gestation when compared to d 85 or
140 in beef cows (Hart et al., 2014). Also, CYP3A was not different between cattle that
had been nutrient restricted (60% of NRC requirements) compared to non-nutrient
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restricted cattle beginning on d 30 of gestation until d 140 of gestation (Hart et al., 2014).
In vivo uterine expression and/or activity of CYP3A has not been examined to date.
Phase II Steroid and Eicosanoid Metabolism
Introduction
Uridine diphosphate-glucuronosyltransferase (UGT) is a membrane-bound
enzyme that is part of the second phase of P4 metabolism which conjugates
hydroxyprogesterone metabolites with glucuronic acid. This reaction is initiated by
transferring a glucuronosyl group from the uridine 5’-diphospho-glucuronic acid
(UDPGA) resulting in a more polar substance which is easier to move within the blood to
the kidneys where they are filtered out and finally excreted via urination (RadominskaPandya et al., 1998). In addition to steroids and eicosanoids, UGT enzymes are well
established catalyzers of several drugs and are often referred to as a “drug metabolizing
enzyme” or DME. The UGTs exhibit 117 different members within mammalian species
with the genetic homology being at least 40% between families and upwards of 60%
between isoforms (Jancova et al., 2010). Multiple isoforms are found throughout the
human body including the kidney, adipose tissue, lung, skin, intestines, and brain;
however, the primary location is the liver, similar to the phase I enzymes (Collier et al.,
2002).
UDP-glucuronosyltransferase 1 (UGT1)
Interestingly, mice that utilized in-vitro fertilization and intra-cytoplasmic sperm
injection to achieve pregnancy, yielded 61-fold and 106-fold greater mRNA,
respectively, for UGT1A1 within the placenta when compared to pregnancies achieved
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through a natural mating (Collier et al., 2012). Healthy post-menopausal women have
yielded expression of UGT1A1 mRNA in endometrial tissues. Human endometrial
cancer cell lines exhibited greater activity of UGT1A1 when treated with the substrate 2hydroxyestradiol compared to the substrate 4-hydroxyestradiol (Duguay et al., 2004).
Mouse placental UGT1A1 and UGT1A2 mRNA was negatively correlated with tissue
lysate levels of P4 (r = -0.52, P = 0.007) and cholesterol (r = -0.45, P = 0.018),
respectively (Collier et al., 2012). However, variants of the UGT1A subfamily were not
found using Western blotting, qPCR, and immunohistochemistry in human term placental
tissues (Collier et al., 2002). Estrogen receptor alpha transfected cells, HepG2, that were
stimulated with estradiol expressed a significantly greater UGT1A4 expression compared
to those cells that did not exhibit estrogen receptor alpha (Chen et al., 2009). In humans,
UGT1A8 is primarily found extrahepatically, which indicates that it may have a role in
the regulation of peripheral concentrations of hormones (Collier et al., 2002).
UDP-glucuronosyltransferase 2 (UGT2)
There are two separate subfamilies of UGT2, UGT2A that is found within nasal
tissue, and UGT2B has been identified in human liver cells as well as extra hepatic
tissues, kidney, prostate, mammary gland, and ovary (Strassburg et al., 1999; Albert et
al., 2000; Juengel et al., 2000). In addition, UGT2B is highly involved in androgen
clearance and is more greatly active in patients with prostate cancer (Nadeau et al., 2011).
Human term placentas showed the presence of UGT2B4 and 2B7 using both Northern
and Western blotting techniques, however the band intensities were different when
comparing Western blot procedures (Collier et al., 2002).
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Uterine Blood Perfusion
Blood flows through the body via arteries to get to tissues, where it is then
perfused through capillary beds for nutrient and waste exchange (Gannon et al., 1997).
Ford and Chenault (1981) determined a negative correlation (r = -0.25, P < 0.05) between
P4 and uterine blood flow. Conversely, E2 increases blood flow to the uterus (Ford and
Chenault, 1981; Ford, 1982) and endometrium (Gannon et al., 1997) of cattle and swine.
This increased blood flow and perfusion in humans has been indicative of endometrial
receptiveness and poor uterine perfusion is one cause of failure of implantation of
embryos (Gannon et al., 1997; Yang et al., 1999; Sarnik et al., 2007; Barad et al., 2014).
Measurement of endometrial perfusion via laser Doppler fluxmetry is a non-invasive
procedure that has been used in human medicine and research for years (Gannon et al.,
1997; Barad et al., 2014). In humans, an increase in uterine perfusion exists during the
early follicular phase, during increased production of E2, as compared to the menses or
ovulation phase of the menstrual cycle (Gannon et al., 1997). Conscious human subjects
exhibited a varied amount of endometrial blood perfusion, whereas anaesthetized patients
did not exhibit variable perfusion across the regions of the uterus and endometrium
(Gannon et al., 1997).
Several researchers have utilized various techniques to measure uterine blood
flow using color Doppler ultrasonography (Lemley et al., 2012; Brockus et al., 2016) or
surgically implanted transducers (Ford and Chenault, 1981). Infusion of radioactive
microspheres have been utilized to measure endometrial perfusion, but this technique is
terminal and cannot be used during extended repeated samplings (Rosenfeld et al., 1973).
In sheep, blood flow to the uterus and mammary gland ultimately increases to result in
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18% of total cardiac output, which is the amount of blood pumped by the heart per
minute by multiplying heart rate and stroke volume (Rosenfeld, 1977; Clapp, 1978). In
cattle, uterine artery blood flow increases by 250% and heart rate by 118% from days 180
to 262 days of gestation (Brockus et al., 2016b).
Angiogenic factors
Vascularization is greatly dependent upon vasculogenesis and angiogenesis
(Bruno et al., 2009) with several key factors assisting with one or both and are vital to the
development of the placenta.
Vascular Endothelial Growth Factor
A key angiogenic protein is vascular endothelial growth factor (VEGF). Actions
of VEGF include stimulation of endothelial cell migration, increased in capillary
permeability, and it acting like a survival factor for endothelial cells (Bruno et al., 2009).
It is variably expressed in intercaruncle tissue across the estrous cycle of cattle, with the
greatest expression accompanying the early stages of diestrus during CL formation
(Tasaki et al., 2010). Vascular endothelial growth factor positively affects primordial
follicle survival, mitogenic effects on granulosa cells, and assists in the transitions
between primary to secondary follicles (Bruno et al., 2009). Supplementation of VEGF to
cattle bovine pulmonary artery endothelial cells significantly decreases the amount of
basal tension and increases the diameter within the pulmonary artery (Jacobs et al., 2006).
Nitric Oxide
Nitric oxide synthases are cytochrome enzymes that require three co-substrates
(L-arginine, NADPH, and oxygen) and several other cofactors and prosthetic groups to
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synthesize nitric oxide (NO; Nathan and Xie, 1994). Nitric Oxide Synthase 3 is also
known as eNOS or endothelial, constitutive nitric oxide synthase. Bovine endometrial
stromal cells exhibited a lack of stimulation by supplementation of TNFα or oxytocin to
increase expression of NOS3, which typically increases the expression of NOS3 in luteal
cells (Woclawek-Potocka et al., 2004; Skarzynski et al., 2009). Nitric oxide assists with
angiogenesis (Nathan and Xie, 1994) and mediates vasodilatory responses in muscular
arteries (Ignarro et al., 1987). Supplementation of 17β-estradiol significantly increases
uterine blood flow within 2 hr of administration and is interrelated with the concentration
of nitrites, a metabolite of nitric oxide, in the system (Van Buren et al., 1992).
Supplementation of increasing increments of metabolizable protein also increased serum
nitrites in pregnant ewes, but also tended to decrease uterine blood flow (Lekatz et al.,
2015). Metabolites of NO, nitrites, increases in maternal serum as gestation progresses
from d 180 through d 240 of gestation in Holstein heifers (Brockus et al., 2016b).
Melatonin
Melatonin (N-acetyl-5-methoxytryptamine) is a neurohormone secreted primarily
by the pineal gland during scotophase and acts as a powerful antioxidant (Reiter et al.,
2009). This hormone is widely known to regulate sleep wake cycles and reproductive
cyclicity in seasonal breeding animals, and is involved in pigmentation in the dermal
layer of some species, protects DNA within the nucleus and mitochondria, and influences
pubertal development (Reiter et al., 2006; Pandi-Perumal et al., 2008; Reiter et al., 2009).
Melatonin acts as a powerful antioxidant (Reiter et al., 2009) that reduces oxidative stress
on reproductive tissues through direct and indirect action. Directly, melatonin binds to its
receptors that influences either vasoconstriction or vasodilation (Dubocovich and
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Markowska, 2005), and indirectly via the Nitric Oxide pathway (Pandi-Perumal et al.,
2008) which reduces the number of reactive oxigen species.
Melatonin Receptors
Melatonin is facilitated by two G-protein coupled receptors labelled MT1 and
MT2 (Morgan et al., 1994; Dubocovich and Markowska, 2005; Pandi-Perumal et al.,
2008). Receptor MT1 has a greater affinity for melatonin as compared to MT2, and is
primarily found in the brain, small intestine, ovary, lung, cardiac tissues, and
myometrium (Dubocovich and Markowska, 2005; Pandi-Perumal et al., 2008). Melatonin
elicits the dilation of cardiac vessels through the MT2 receptor, but constriction of cardiac
vessels through the MT1 receptor. Recently, a third melatonin receptor (MT3) has been
found but belongs to the family quinone reductases, which regulate transcription factors
that code for apoptosis (Witt-Enderby et al., 2003). This MT3 receptor is known to elicit
metabolic and antioxidative effects.
Therapeutic Administration to Livestock
Previous research in our laboratory demonstrated similar birth weights in calves
from cattle which were orally supplemented with melatonin. However, calves from the
melatonin-supplemented dams increased in BW and heart girth at 9 wk of age compared
to calves from non-supplemented dams (Brockus et al., 2016a). Supplementation of
melatonin to semen extender has been noted to improve freeze-thaw survivability in bulls
and buffalo (Cruz et al., 2014). The addition of 500 mg of melatonin to beef tallow
administered to multiparous cattle increased the interval between calving to first estrus
and ovulation (Sharpe et al., 1986). Dietary enhancement of melatonin (20 mg per day)
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throughout the last third of gestation increased uterine blood flow, heart rate, and total
antioxidant capacity, but it decreased maternal serum estradiol-17β and P4 concentrations
(Brockus et al., 2016b). Intrauterine infusion and dietary supplementation of melatonin to
sheep, increases umbilical artery blood flow, fetal descending aorta, abdominal girth,
kidney size, and lamb weights one month after weaning (Forcada et al., 1995; Lemley et
al., 2012; Lemley et al., 2013b; Eifert et al., 2015). However, melatonin supplementation
decreases caruncle and cotyledon weights (Lemley et al., 2013b; Eifert et al., 2015).
Umbilical blood flow increases within 10 days of initiation of supplementation in ewes
along with a 58% increase in the occurrence of twins and reduced the proportion of nonpregnant ewes (Williams et al., 1992; Lemley et al., 2012).
Implications and Conclusions
There are over 92 million cattle in the U.S. that contains almost 50 million cows
and heifers with an annual pregnancy rate of 75% (Minton et al., 1992; National
Cattlemen’s Beef Association, 2015; Jones, 2017). This loss in pregnancy rates or
infertility and embryonic mortality costs the beef industry over $1.63 billion annually
(Minton et al., 1992; National Cattlemen’s Beef Association, 2015; Jones, 2017). A
typical estrous cycle in cattle lasts approximately 21 days and is divided into two primary
phases: the follicular and the luteal phase, which are named for the primary structure in
the ovary at the time. The conceptus within the uterus around d 15 of the estrous cycle,
during the late luteal phase, begins to secrete IFNτ which has significant impacts on the
CL and uterus as outlined above under maternal recognition of pregnancy. One primary
impact is the production of hormones including steroids and oxylipins, which aids in the
angiogenesis and blood flow to the CL and uterus. This localization of oxylipins that are
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differentially expressed in CL of pregnant as compared to non-pregnant females could
accommodate future research to determine pregnancy earlier than current methods. Also,
characterization of these localized oxylipins within the CL could allow for identification
of dysfunctional CL.
An increase in vascularity and endometrial perfusion has been linked to increased
reproductive receptivity in humans (Gannon et al., 1997; Yang et al., 1999); however,
utilization of this technique has not been utilized in livestock to date. Measurement of
endometrial perfusion may provide an additional breeding soundness evaluation for cows
and heifers. Metabolism of steroids and eicosanoids occurs in two phases, CYP and UGT,
with a paucity of information on these enzymes in extra hepatic tissues within livestock
animals. Hydroxyestrogens have been noted to have anti-embryonic properties, which led
us to evaluate the CYP1A and 3A activity, without success, in cyclic and early pregnant
endometrium. Production of EET by CYP2C has exhibited anti-inflammatory effects and
analysis of CL tissues for activity of CYP2C failed. However, localization of UGT within
endometrial tissues was a success and could provide evidence for localized clearance of
steroid metabolites and oxylipin via glucuronidation.
Research into therapeutic substances for improvement of reproductive success is
critical for improved profitability. Our lab has previously done research with the
supplementation of melatonin to cattle. Supplementation with melatonin has yielded an
increase in enzyme activity of CYP within the liver, uterine blood flow, and umbilical
blood flow (Lemley et al., 2012; Lemley et al., 2013a; Brockus et al., 2016b). Increasing
the activity of the CYP via supplementation of melatonin could provide an increased
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production of oxylipins, either pro- or anti-inflammatory and embryonic, which could
provide a greater chance of maintaining a pregnancy.

Figure 1

Proposed interactions between luteotrophic and luteolytic pathways
in ruminants

Proposed interactions between luteotrophic and luteolytic pathways in the choice between
pregnancy and a return to cyclicity in polyestrus ruminants, in which IFNτ is the maternal
recognition of pregnancy signal and there is no decidualization. (Redrawn from Cheng et
al., 2007)
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Figure 2

Adaptation of prostaglandin pathway

(Redrawn from Canby-Hagino and Thompson, 2005)
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Figure 3

Cytochrome P450 metabolism/hydroxylation of progesterone and
estrogen.
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CHAPTER II
EXAMINING ENDOMETRIAL BLOOD PERFUSION USING A NOVEL LASER
DOPPLER TECHNIQUE IN ANGUS COWS THROUGHOUT THE ESTROUS
CYCLE
Abstract
Previous studies have characterized ovarian steroid synthesis which directly
affects uterine environment and blood flow. Clearance of steroids occurs primarily in
hepatic tissues, however, we discovered abundant activity of the phase II steroid
metabolizing enzyme UDP-glucuronosyltransferase (UGT) in uterine biopsies. No
minimally invasive techniques for collecting endometrial perfusion, which is affected by
steroids and indicative of reproductive health, have been proposed for livestock. We
aimed to characterize UGT activity and endometrial blood perfusion during a normal
bovine estrous cycle. We hypothesized increased steroid metabolism during the luteal
phase of the estrous cycle and in the uterine horn ipsilateral to the corpus luteum (CL).
During the first synchronized estrous cycle, progesterone and UGT activity increased on
day 6 compared to day 0 and 3. Endometrial perfusion was increased ipsilateral to the CL
versus contralateral on day 12, and decreased ipsilateral to the CL versus contralateral on
day 18. Endometrial expression of vascular endothelial growth factor A (VEGFA) was
decreased on day 18, whereas expression of NOS3 was least on day 12 and greatest on
day 18. Similar to perfusion results, nitric oxide metabolites (nitrites) were greatest in the
endometrium ipsilateral to the CL as compared to contralateral. Moreover, a positive
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correlation (r = 0.28; P = 0.04) was observed between endometrial perfusion and nitrite
concentration. We conclude activity of UGT within the endometrium is affected by the
location of the CL, and collection of endometrial perfusion using a laser Doppler probe
could be a viable measurement that is supported by nitrite concentration.
Introduction
Progesterone (P4) has been noted to elicit a variety of responses (Lau et al., 1993;
Spencer et al., 1996; Atkinson et al., 1998) in the cow’s body to prepare the reproductive
tract for an impending pregnancy. Production of P4 is primarily performed by the corpus
luteum (CL), which is the predominant ovarian structure from days 4 through 16 of the
cow’s estrous cycle (Walters et al., 1984; Ginther et al., 1989). Metabolism of P4 occurs
in two phases (Giantin et al., 2008), beginning with phase I cytochrome P450 2C
(CYP2C) and 3A (CYP3A) converting P4 into hydroxyprogesterone metabolites (Lemley
et al., 2010) which are further conjugated to glucuronic acid by the phase II enzyme
uridine 5’-diphospho-glucuronosyltransferase (UGT; Hart et al., 2014). A majority of
steroid metabolism occurs in the liver, but others have shown UGT expression and/or
activity in several extra-hepatic tissues in cattle, such as kidneys, lungs, small and large
intestines, and brains (Iwano et al., 2001; Darwish et al., 2010; Girolami et al., 2016).
Our preliminary studies have shown minimal to no activity of phase I enzymes in bovine
reproductive tissues (Owen and Lemley, unpublished). Conversely, our preliminary
studies have shown abundant activity of UGT enzymes in bovine reproductive tissues,
which deserves further investigation. Uterine biopsies have been utilized in the cattle and
horse industries as a valuable method of detecting endometrial health and assessing the
bacterial load within the uterine environment (Ricketts, 1975; Bonnett et al., 1993). Due
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to the vital importance of P4 to the uterine and endometrial mechanisms, an
understanding of the localized metabolism of P4 within the uterus needs to be established.
Therefore, our first aim was to characterize endometrial UGT activity during the normal
bovine estrous cycle. Furthermore, we hypothesized that endometrial UGT activity would
be greatest during the luteal phase, and would be greater in the uterine horn ipsilateral to
the CL.
Progesterone has also been noted to create a type of quiescence of the uterus
which minimized the myometrial contractions and affects the movement of blood through
capillary beds within the endometrium (Grazzini et al., 1998; Soloff et al., 2011).
Conversely, estrogen increased blood flow to the uterus (Ford and Chenault, 1981; Ford,
1982) and endometrium (Gannon et al., 1997) of cattle and swine. This increased blood
flow and perfusion in humans has been indicative of endometrial receptiveness and poor
uterine perfusion is one cause of failure of implantation of embryos (Gannon et al., 1997;
Yang et al., 1999). Collection of endometrial blood perfusion via laser Doppler fluxmetry
is a non-invasive procedure that has been used in human medicine and research for years
(Gannon et al., 1997; Barad et al., 2014). In humans, an increase in uterine perfusion
exists during the early follicular phase, during estrogen-dominance, as compared to the
menses or ovulation phase of the menstrual cycle (Gannon et al., 1997). Several
researchers have appled various techniques to measure uterine blood flow using color
Doppler ultrasonography (Lemley et al., 2012; Brockus et al., 2016) or surgically
implanted transducers (Ford and Chenault, 1981). Infusion of radioactive microspheres
have been applied to measure endometrial perfusion, but this technique is terminal and
cannot be used during extended repeated samplings (Rosenfeld et al., 1973). There are no
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minimally invasive or non-terminal techniques to acquire endometrial perfusion in
livestock species, which led us to our second objective: validating laser Doppler to
examine bovine endometrial perfusion in relation to angiogenic factor expression and
total endometrial nitrite concentrations during the estrous cycle. We hypothesized that
endometrial blood perfusion would be greater ipsilaterally to the dominant follicle.
Therefore, our objectives through these hypotheses were to determine endometrial UGT
enzyme activity, angiogenic factor expression, and endometrial blood perfusion in
relation to the CL and dominant follicle (DF) during a normal bovine estrous cycle.
Materials and Methods
Experiment 1
Animal care and treatments
Animal care and use were according to protocols approved by the Mississippi
State University Institutional Animal Care and Use Committee. Cattle were maintained
on winter pasture and allowed ad libitum access to native pasture hay and water. Twentyone non-pregnant Angus cows had their estrous cycles synchronized using a modified 7day CO-Synch + CIDR protocol. Briefly, a 2 ml, i.m injection of GnRH (Factrel, Fort
Dodge Animal Health, Fort Dodge, IA, USA) was administered, a CIDR (Eazi-Breed™
CIDR® Cattle Insert, Zoetis, Parsippany, NJ, USA) was placed in the vagina of cows for
7 days, upon CIDR removal cattle were administered 5 ml, i.m Lutalyse (Zoetis,
Parsippany, NJ, USA), and estrus was detected in 60 ± 6 hrs. Cows were enrolled in the
study on their first day of estrus, using observational indications along with Estrotect™
Heat Detection patches (Rockway Inc., Spring Valley, WI, USA), which was considered
day 0 of the study. Four cows were removed from the study due to lameness issues (1
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cow) and lack of response to estrous synchronization (3 cows) for the first estrous cycle.
Uterine biopsy and blood samples were collected on days 0, 3, 6, and 9 for the first
estrous cycle. Cattle were allowed to finish this first synchronized estrous cycle with no
further samples collected. A consecutive set of samples, similar to the first estrous cycle,
were collected on days 12, 15, 18, and 21 of the second estrous cycle after undergoing
estrous synchronization similar to the first estrous cycle. Five cows were removed from
the study due to failure to respond to estrous synchronization. Only cattle that exhibited a
normal estrous cycle, as determined by peripheral P4 profiles, were maintained
throughout the analysis portion of the study. Due to this criterion, 3 cows were removed
from the first estrous cycle and 2 cows were removed from the second estrous cycle
analysis. Also, due to this criterion 10 out of 13 cattle showed a decrease in peripheral P4
profiles on day 9 and therefore day 9 was removed from the analysis.
Sample collection
Cattle were subjected to rectal ultrasonography on day 6 of the first estrous cycle
and day 11 and 19 of the second estrous cycle to determine CL and follicular locations
and collect ultrasound images. These images were used to determine the diameter and
volume of the CL and DF using image J software following previously published
methods (Vasconcelos et al., 2001). Also, on each sampling day (days 0, 3, 6, and 9 of
the first estrous cycle and days 12, 15, 18, and 21 of the second estrous cycle) blood was
collected via venipuncture of the coccygeal vein for hormone analysis. Serum tubes were
incubated at room temperature for at least 30 min prior to being centrifuged and plasma
tubes were inverted several times and held on ice for transportation. Centrifugation was
performed at 4°C for 15 min at 2000 x g. Serum and plasma were harvested and
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subsequently stored at -80°C until assayed. Cattle were subjected to an endometrial
biopsy utilizing a mare uterine biopsy punch (Mare Uterine Biopsy Punch 27”, Santa
Cruz Biotechnology Inc., Dallas, TX, USA) with a sample collected from each horn and
snap frozen in liquid nitrogen.
Tissue processing
Approximately 50 mg of tissue was placed into a polypropylene tube with 500 µL
of potassium phosphate (KPO4) buffer (400 mM, pH = 7.4). Samples were then
mechanically homogenized using the Tissue Tearor (Biospec Products, Bartlesville, OK,
USA) following the manufacturer’s protocol. Tissue homogenate samples were placed
into microcentrifuge tubes and then centrifuged at 10,000 × g for 10 min at 4°C. The
supernatant was stored at −80°C until enzyme assays were conducted. The protein
concentration of the supernatant was determined by a Coomassie Plus (Bradford) protein
assay following the manufacturer’s protocol (Thermo Scientific, Rockford, IL, USA) and
diluted to a concentration of 4000 µg/mL.
UGT assay
The UGT assay kit was purchased from Promega Corporation (Madison, WI,
USA) and the assay performed according to Hart et al. (2014) with minor adaptations.
Briefly, uridine diphosphoglucoronic acid (UDPGA) was added to half the plates to act as
reaction wells, and distilled water was added to the other half as control wells. The UGT
reaction mixture containing UGT multienzyme substrate was then combined with tissue
homogenates (28 µg of tissue protein per well), and the plates were preincubated for 90
min at 37°C. After incubation, detection reagent was added to each of the wells followed
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by an incubation period of 20 min at room temperature while protected from light. The
plates were then analyzed using a Promega Multi- Plus plate reader with luminescence
detection mode.
Hormone analysis
Serum hormone analysis was determined using a P4 radioimmunoassay kit
performed following the manufacturer’s instructions (MP Biomedicals, LLC, Solon, OH,
USA) and Cline et al., 2016. Briefly, standards, control samples, and serum samples were
allowed to thaw at room temperature and 100 µL of each were pipetted into their
respective tubes. The total and non-specific binding tubes that serve as controls utilized
clear, non-coated polypropylene tubes whereas the standards and serum samples utilized
the ImmuChem Progesterone Coated Tubes that were provided in the kit. After all
samples were allocated into their respective tubes, 1.0 mL of iodinated P4 was added and
allowed to incubate in 37°C water bath for 2 hours. The samples were then decanted and
placed into a gamma counter (Packard Instrument Company, Meriden, CT, USA).
Samples falling below the detectable limit (0.02 ng/mL) were presumed to have 0.02
ng/mL for further statistical analysis. Inter- and intra-assay CV were 6.6 and 8.2%
respectively.
Experiment 2
Animal care and treatments
Animal care and use were according to protocols approved by the Mississippi
State University Institutional Animal Care and Use Committee. Cattle were maintained
on winter pasture and allowed ad libitum access to native pasture hay and water. Twenty
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non-pregnant Angus cows had their estrous cycles synchronized using a modified 7-day
CO-Synch + CIDR. Cows were enrolled in the study on their first day of estrus, using
observational indications along with Estrotect™ Heat Detection patches, which was
considered day 0 of the study. Five cows were removed from the study due to failure to
respond to estrous synchronization. A consecutive set of samples, similar to the first
experiment, were collected on days 12, 15, 18, and 21 of the second estrous cycle. This
second set of samples included the collection of endometrial perfusion using a novel laser
Doppler probe (PeriFlux 5000 LDPM, Perimed Inc., Ardmore, PA, USA). Only cattle
that exhibited a normal estrous cycle, as determined by P4 hormone profiles, were
maintained throughout the analysis portion of the study. Due to this criterion, 2 cows
were removed from the analysis.
Sample collection
Prior to endometrial biopsies, an equine artificial insemination rod was passed
through the cervix and into each uterine horn of the cow. Next, the laser Doppler
perfusion probe was inserted through the artificial insemination rod until gaining contact
with the uterine endometrium. The correct distance for insertion through the lumen of the
artificial insemination rod was marked with laboratory tape. The laser Doppler probe
collected endometrial blood perfusion and microvascular flow of the tissue surface
without traumatizing the endometrium. This probe utilizes a 780-nm wavelength laser,
with a measuring depth of approximately 0.5 – 1.0 mm, in order to collect blood
perfusion. Optimal perfusion was obtained by selecting 10 sec of relatively constant
perfusion for measurement, as measured by arbitrary Perfusion Units (PU) following
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calibration of the middle of each uterine horn. After blood perfusion was collected, cattle
were subjected to an endometrial biopsy similar to Experiment 1.
Tissue processing
Total RNA was extracted from individual uterine biopsy samples using the
Qiagen miRNeasy kit (Qiagen, Hilden, Germany) according to the manufacturers’
protocols. Briefly, approximately 100 mg uterine biopsy sample was mechanically
homogenized in 700 µL Quizol. Protein was precipitated via the addition of chloroform,
agitation, and the upper aqueous phase was purified through a series of ethanol washes
through the column provided in the kit. Finally, 30 µL of nuclease-free water was passed
through the column to free the RNA. The RNA was quantified using UV-Vis
Spectrophotometer (NanoDrop One, Thermo Scientific, Rockford, IL, USA), and RNA
was diluted to a constant concentration (650 ng/µL). The diluted RNA treated with
DNase then made into cDNA using the QuantiNova Reverse transcription kit (Qiagen,
Hilden, Germany) in the Eppendorf Mastercycler gradient (Applied Biosystems, Foster
City, CA, USA). Equal amounts of cDNA from each sample were pooled for analysis to
represent the average expression of mRNA for all uterine biopsies.
Quantitative RT-PCR
Real time PCR (RT-PCR) was performed using the QuantiNova SYBR Green
PCR Kit (Qiagen, Hilden, Germany) instructions in the Rotor Gene Q (Qiagen, Hilden,
Germany). Primers for Nitric Oxide Synthase 3 (NOS3), Vascular Endothelial Growth
Factor A (VEGFA), and B-Actin were ordered from Invitrogen Custom Primers and the
sequences and information are in Table 1. Reactions for each gene were run in duplicate.
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A temperature gradient PCR reaction was run for all of the primer sets to determine the
optimal annealing temperatures. According to gradient PCR, the optimal annealing
temperature of all primer sets overlapped at 60°C. Correspondingly, the following
protocol was designed and applied to all RT-PCR reactions: I) 1 cycle at 95°C for 2 min;
II) 40 repeat cycles at 95°C for 5 sec., followed by annealing at 60°C for 10 sec.; III)
60.0°C-95.0°C with melting temperature increasing 0.5°C for each 30 sec. Fluorescence
was detected at both step II and III. Real time analysis was enabled at step II, and melt
curve data collection and analysis enabled at step III. An amplification efficiency of 95 –
105% was reached for all the RT-PCR reactions in this study. Final data was analyzed
through the 2-ΔΔCt method where B-actin was used as a reference gene to normalize all the
selected gene expression data.
Tissue nitrite
Total tissue nitrites were determined in uterine biopsy homogenates (prepared as
stated above) from days 12, 15, 18, and 21. Total tissue nitrites were determined using
the QuantiChrom Nitric Oxide Assay Kit (BioAssay Systems, Hayward, CA, USA).
Briefly, homogenized tissues were deproteinized following the manufacturer's
recommendations, and samples were quantified following the reduction of total nitrates to
nitrites using the Griess method and analyzed against a linear nitrite standard curve (0–
100 μM), with a sensitivity of 0.6 μM and interassay coefficient of variation of 7.1%.
Tissue nitrites are expressed as micromole per gram of uterine biopsy (μM/g of Ut.
Biop.).
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Statistical analysis
Enzyme activity for UGT was expressed relative to milligram of protein and
tissue nitrites are expressed as micromole per gram of uterine biopsy. Data were analyzed
using repeated measures ANOVA of the MIXED procedure of SAS (SAS Inst. Inc.,
Cary, NC, USA). Means were separated using the PDIFF option of the LSMEANS
statement. The model statement included day of estrous cycle, CL and DF location
(respective to each uterine horn), and the respective interactions with day. Pearson
correlation coefficients were determined using the CORR procedure of SAS to analyze
the relationships between CL and DF location (respective to each uterine horn),
endometrial blood perfusion, CL and DF size, and P4. Statistical significance was
declared at P ≤ 0.05, and tendencies discussed when P ≥ 0.06 but P ≤ 0.10.
Results
Serum P4 concentrations and UGT (Experiment 1)
A significant day effect (P < 0.001) was observed from days 0 to 6 and for days
12 to 21 for serum P4 concentrations (Figure 4A and 4B). Serum P4 concentrations on
days 0 and 3 were not different, but day 6 was greater (P ≤ 0.05) than both day 0 and 3
for the first estrous cycle (Figure 4A). Days 12 and 15 had greater (P ≤ 0.05) serum P4
concentrations as compared to days 18 and 21 of the second estrous cycle (Figure 4B). A
significant day effect (P = 0.0005) was observed from days 0 to 6 for UGT activity of the
first estrous cycle (Figure 4C). Activity of UGT, expressed as mg of protein, on days 0
and 3 were not different, but day 6 was greater (P ≤ 0.05) than both day 0 and 3 for the
first estrous cycle. However, the second estrous cycle exhibited a CL side by day
interaction (P = 0.03) with the UGT activity tending to be greater in the endometrial
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biopsy samples ipsilateral to the CL on days 15 and 21, (P = 0.06 and P = 0.08,
respectfully; Figure 4D).
Endometrial Perfusion (Experiment 2)
Schematic drawings of the collection of endometrial perfusion are in Figure 5 in
relation to the CL (A) and dominant follicle (B). A significant CL side by day interaction
(P = 0.01) was observed for endometrial perfusion. Endometrial perfusion was greater (P
≤ 0.05) on the ipsilateral horn to the CL as compared to the contralateral side on day 12.
On day 15 endometrial perfusion was not different between the two uterine horns.
Endometrial perfusion contralateral to the CL was greater (P ≤ 0.05) on day 18 as
compared to endometrial perfusion ipsilateral to the CL. Endometrial perfusion tended to
be greater (P = 0.08) on the ipsilateral horn to the CL as compared to the contralateral
side on day 21 (Figure 5A). Conversely, no significant dominant follicle side by day
interaction was observed for endometrial perfusion across days 12 through 21 of the
second estrous cycle in Experiment 2 (Figure 5B).
Angiogenic factors (Experiment 2)
Endometrial expression of VEGFA and NOS3 are illustrated in Figure 6. A
significant day effect (P = 0.009) was observed from days 12 to 21 for expression of
VEGFA (Figure 6A). On day 12 VEGFA expression was greater compared with days 15,
18, and 21. Expression of VEGFA was not different between day 15 and 21. Expression
of VEGFA was least on day 18 as compared to days, 12, 15, and 21. A tendency for a day
effect (P = 0.08) was observed from days 12 to 21 for expression of NOS3 (Figure 6B).
Endometrial expression of NOS3 was increased on day 18 compared with day 15 and 21,
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while day 12 was intermediate. Total tissue nitrites in uterine biopsy samples are
illustrated in Figure 7. The ipsilateral side to the CL yielded greater concentrations of
tissue nitrites (P = 0.0005) at day 12 as compared to the contralateral side to the CL.
Discussion
Previous studies have focused on activity of UGT in hepatic tissues; however, our
study examined the activity of UGT in endometrial tissues. Activity of UGT displayed
similar trends during the first synchronized estrous cycle with circulating serum P4
concentrations increasing from day 0 to 6. This is supported by a positive correlation (r =
0.51, P = 0.004) between serum P4 concentrations and the total activity of UGT.
Therefore, as the CL is developing and beginning P4 synthesis it may be activating
steroid metabolizing pathways in the uterus. Activity of UGT enzymes express twice as
much activity when exposed to P4 metabolites as compared to estrogen metabolites in
monkey tissues (Albert et al., 2000). However, this relationship between P4 secretion and
endometrial activity was not observed in the second estrous cycle. This differential
activity of endometrial activity could be due to the presence of prostaglandins within the
uterus, especially on day 15, which is immediately prior to luteolysis, and day 21, which
could be due to the increased amount of uterine manipulation. Day 18 of the second
estrous cycle occurs during the early proestrus phase (Hurnik et al., 1975) and indicates a
low concentration of P4, which coincides with the current studies circulating serum P4
concentrations. Greater UGT activity tended to be ipsilateral to the CL on day 21 of the
second estrous cycle. Activity of UGT is greatest during the luteal phase, which supports
our hypothesis; however, UGT activity tended to be greater ipsilateral to the CL on days
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15 and 21 as compared to the contralateral horn to the CL, which contradicts the
hypothesis that UGT activity would be greater ipsilaterally to the CL.
Uterine blood flow is increased when concentrations of estradiol are greatest in
cattle within one day of estrus as compared to other days of the estrous cycle (Ford and
Chenault, 1981). Ovariectomized ewes, supplemented with estradiol and injected with
radiolabeled microspheres (Rosenfeld et al., 1973), also exhibited greater uterine blood
flow. Endometrial perfusion, as measured by laser Doppler fluxmetry, has been
increasing in popularity in human medicine (Gannon et al., 1997; Sarnik et al., 2007;
Barad et al., 2014), and is used as a method of assessing endometrial receptiveness (Yang
et al., 1999), and ability for embryonic implantation (Gannon et al., 1997). Conscious
human subjects exhibited a varied amount of endometrial perfusion, whereas
anaesthetized patients did not exhibit variable perfusion across the regions of the uterus
and endometrium (Gannon et al., 1997). Also, endometrial perfusion was greatest during
the early follicular and secretory phases of the menstrual cycle, which is most analogous
to the estrus and diestrus phases of the cow’s estrous cycle (Sherman and Korenman,
1975). In the current experiment, utilizing laser Doppler fluxmetry, a CL side by day
interaction was observed. Day 12 endometrial perfusion was greatest on the side
ipsilateral to the CL and again tended to be greater on day 21. Increased perfusion on day
12 contradicts previous research, whereby Ford and Chenault (1981) determined a
significant negative correlation (r = -0.25, P < 0.05) between P4 and uterine blood flow.
When analyzing data that contained the dominant follicle on the same side as the CL, the
endometrial perfusion was negatively correlated (r = -0.38, P = 0.04) with the size of the
dominant follicle. Day 15 perfusion was not different between the ipsilateral and
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contralateral sides of the CL, which could be indicative of the transition between diestrus
and proestrus (Hurnik et al., 1975). On day 18, endometrial perfusion was greatest on the
contralateral side of the CL, which could be indicative of the prostaglandin F2A
(PGF2A), that has been secreted from the endometrium, in greater concentration because
the PGF2A secreted on the ipsilateral side to the CL has been shunted to the CL by the
counter-current exchange of the ovarian artery (Einer-Jensen and McCracken, 1977;
Krzymowski et al., 1982; Oliveira et al., 2008).
Vascularization is greatly dependent upon vasculogenesis and angiogenesis
(Bruno et al., 2009) with several key factors assisting with one or both, such as VEGF.
Expression of VEGF is variable in intercaruncle tissue across the estrous cycle of cattle,
with the greatest expression accompanying the early stages of diestrus during CL
formation (Tasaki et al., 2010). The VEGF expression in this experiment was also
greatest during the diestrus stage but it was during the mid-diestrus stage (day 12). The
lowest VEGFA expression in this experiment was during the proestrus period, which is
similar to previous results of VEGFA protein expression in intercaruncle tissue of cattle
(Tasaki et al., 2010). Assemblage of uterine biopsies allows for collection and assessment
of intercaruncular and caruncular tissues. In this experiment, VEGFA expression was
intermediate on days 15 and 21 of the estrous cycle, while previous studies have
indicated that VEGF mRNA expression was also greatest during this stage of the estrous
cycle (Tasaki et al., 2010).
Nitric oxide synthases are cytochrome enzymes that require three co-substrates
(L-arginine, NADPH, and oxygen) and several other cofactors and prosthetic groups to
synthesize NO (Nathan and Xie, 1994). Nitric Oxide Synthase 3 is also known as eNOS
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or endothelial, constitutive nitric oxide synthase. Bovine endometrial stromal cells
exhibited a lack of stimulation by supplementation of TNFA or oxytocin to increase
expression of NOS3, which typically increases the expression of NOS3 in luteal cells
(Woclawek-Potocka et al., 2004; Skarzynski et al., 2009). In this experiment, NOS3
expression tended to have a day effect and was greatest at day 18 of the estrous cycle.
When analyzing data that contained the dominant follicle on the opposite side as the CL,
the NOS3 expression tended to be positively correlated (r = 0.35, P = 0.08) with the
endometrial perfusion collected via laser Doppler fluxmetry.
Nitric oxide assists with angiogenesis (Nathan and Xie, 1994) and mediates
vasodilatory responses in muscular arteries (Ignarro et al., 1987). Supplementation of
17B-estradiol significantly increases uterine blood flow within 2 hours of administration,
and is interrelated with the concentration of NO, a metabolite of nitric oxide, in the
system (Van Buren et al., 1992). However, in the current study the greatest concentration
of NO occurred on day 12 in the biopsies ipsilateral to the CL. Concentrations of NO
were correlated (r = 0.28, P = 0.04) with the endometrial perfusion collected via laser
Doppler fluxmetry across all data collected in Experiment 2. When analyzing data from
uterine biopsy samples contralateral the CL, NO concentration was correlated (r = 0.53, P
= 0.005) with endometrial perfusion collected via laser Doppler fluxmetry. This explains
the lack of differences between the NO concentration in uterine biopsy samples ipsilateral
or contralateral from days 15 through 21.
Activity of UGT was greater during the luteal phase, as we hypothesized, and
mirrored the serum P4 concentrations between days 0 and 6. Activity of UGT within the
uterus and CL indicates localized metabolism of steroids, eicosanoids, and xenobiotics
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throughout the estrous cycle. Endometrial perfusion ipsilateral to the CL follows a similar
profile to the main effect of VEGFA expression across days 12 to 21 of the estrous cycle.
Endometrial perfusion was greater on day 12 ipsilateral to the CL as well as VEGFA
expression and concentration of NO, which support the validity of this novel collection of
endometrial perfusion in cattle. Collection of endometrial perfusion provides the ability
to gather localized blood flow and could have future implications towards more effective
estrous synchronization techniques, improved uterine involution during the post-partum
period, or be utilized during breeding soundness exams for future female breeding stock.
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Table 1
Gene

Details of genes targeted for RT-PCR analysis in Experiment 2a.
Direction Primer Sequence (5’ to 3’)

Amplicon
Length
Forward
GTCCTGTGCATGGATGAGTATG
22
NOS3
Reverse
GCTGTTGAAGCGGATCTTGTA
21
Forward
GCAGATTATGCGGATCAAACCT
22
VEGFA
Reverse
TTCTTTGGTCTGCATTCACATTTGT 25
Forward
GTCGACACCGCAACCAGTT
19
B-Actin
Reverse
AAGCCGGCCTTGCACAT
17
a
All primer pairs were designed to amplify efficiently, produce a single amplicon, not
generate primer–dimers and produced BLAST specificity to expressed gene. Amplicon
length for each primer are reported.
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Figure 4

Circulating progesterone profile and UGT activity in endometrial biopsies
across the estrous cycle in cattle in Experiment 1.

(A) Progesterone concentrations from day 0 through day 6 of the first estrous cycle and
(B) progesterone concentrations from day 12 through day 21 of the second estrous cycle
(C) Enzyme activity of UGT in endometrial biopsies from day 0 through day 6 of the first
estrous cycle and (D) enzyme activity of UGT in endometrial biopsies from day 12
through day 21 of the second estrous cycle. Means with a different letter represent a
significant difference (P < 0.05). Means with a dagger (†) represent a tendency (0.06 ≤ P
≤ 0.10) within day.
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Figure 5

Schematic showing placement of the laser Doppler probe as well as
microvascular perfusion data collected in Experiment 2.

(A) Schematic drawing of the uterus with the laser Doppler probe inserted into the uterus
on the ipsilateral horn to the CL of cows to collect endometrial blood perfusion that is
indicated in blue, and the graph that represents the CL side by day interaction with the
asterisk (*) representing a significant difference (P ≤ 0.05) and a dagger (†) representing
a tendency (0.06 ≤ P ≤ 0.10) within day. (B) Schematic drawing of the uterus with the
laser Doppler probe inserted into the uterus on the ipsilateral horn to the dominant follicle
of cows to collect endometrial blood perfusion that is indicated in blue, and the graph that
represents the dominant follicle side by day interaction.
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Figure 6

Vascular Endothelial Growth Factor A (VEGFA) and Nitric Oxide Synthase
3 (NOS3) relative expression in endometrial biopsies across the estrous
cycle in cattle in Experiment 2.

(A) Vascular Endothelial Growth Factor A (VEGFA) expression in endometrial biopsies
with different letters representing a significant difference (P ≤ 0.05) between days. (B)
Nitric Oxide Synthase 3 (NOS3) expression in endometrial biopsies with different letters
representing a significant difference (P ≤ 0.05) between days.

57

Figure 7

Total nitrites in uterine biopsy samples across the estrous cycle in cattle in
Experiment 2.

Nitrites in uterine biopsy samples across the days of the estrous cycle in relation to the
side of the CL µmol/gram of tissue. The asterisk (*) represents a significant difference (P
≤ 0.05) between contralateral and ipsilateral nitrite measurements to the CL.

58

References
Albert C, Barbier O, Vallée M, Beaudry G, Bélanger A and Hum DW (2000) Distribution
of Uridine Diphosphate-Glucuronosyltransferase (UGT) Expression and Activity
in Cynomolgus Monkey Tissues: Evidence for Differential Expression of SteroidConjugating UGT Enzymes in Steroid Target Tissues. Endocrinology 141 2472–
2480.
Atkinson S, Adams NR and Martin GB (1998) Role of progesterone in ovarian follicular
growth and development in the sheep. Anim. Prod. Australia 22 233–236.
Barad DH, Yu Y, Kushnir VA, Shohat-Tal A, Lazzaroni E, Lee H-J and Gleicher N
(2014) A randomized clinical trial of endometrial perfusion with granulocyte
colony-stimulating factor in in vitro fertilization cycles: impact on endometrial
thickness and clinical pregnancy rates. Fertility and Sterility 101 710–715.
Bonnett BN, Wayne Martin S and Meek AH (1993) Associations of clinical findings,
bacteriological and histological results of endometrial biopsy with reproductive
performance of postpartum dairy cows. Preventive Veterinary Medicine 15 205–
220.
Brockus KE, Hart CG, Fleming BO, Smith T, Ward SH and Lemley CO (2016) Effects
of Supplementing Holstein Heifers with Dietary Melatonin during Late Gestation
on Growth and Cardiovascular Measurements of their Offspring. Reproduction in
Domestic Animals 51 240–247.
Bruno JB, Matos MHT, Chaves RN, Celestino JJH, Saraiva MVA, Lima-Verde IB,
Araujo VR and Figueiredo JR (2009) Angiogenic factors and ovarian follicle
development. Anim. Reprod. 6 371–379.
Van Buren GA, Yang D and Clark KE (1992) Estrogen-induced uterine vasodilatation is
antagonized by L-nitroarginine methyl ester, an inhibitor of nitric oxide synthesis.
American Journal of Obstetrics and Gynecology 167 828–833.
Cline, G. F., A. M. Muth-Spurlock, B. E. Voelz, C. O. Lemley, and J. E. Larson. 2016.
Evaluating blood perfusion of the corpus luteum in beef cows during fescue
toxicosis1. J. Anim. Sci. 94:90-95. doi:10.2527/jas.2015-9554
Darwish WS, Ikenaka Y, El-Ghareeb WR and Ishizuka M (2010) High expression of the
mRNA of cytochrome P450 and phase II enzymes in the lung and kidney tissues
of cattle. Animal 4 2023–2029.
Einer-Jensen N and McCracken JA (1977) The effect of prostaglandin F2α on the
counter-current transfer of 85krypton in the ovarian pedicle of the sheep.
Prostaglandins 13 763–775.

59

Ford SP (1982) Control of uterine and ovarian blood flow throughout the estrous cycle
and pregnancy of ewes, sows and cows. J. Anim Sci 55 32–42.
Ford SP and Chenault JR (1981) Blood flow to the corpus luteum-bearing ovary and
ipsilateral uterine horn of cows during the oestrous cycle and early pregnancy. J.
Reprod. Fert. 62 555–562.
Gannon BJ, Carati CJ and Verco CJ (1997) Endometrial perfusion across the normal
human menstrual cycle assessed by laser Doppler fluxmetry. Human
Reproduction 12 132–139.
Giantin M, Carletti M, Capolongo F, Pegolo S, Lopparelli RM, Gusson F, Nebbia C,
Cantiello M, Martin P, Pineau T et al. (2008) Effect of breed upon cytochromes
P450 and phase II enzyme expression in cattle liver. Drug Metabolism and
Disposition 36 885–893.
Ginther OJ, Knopf L and Kastelic JP (1989) Temporal associations among ovarian events
in cattle during oestrous cycles with two and three follicular waves. Journal of
Reproduction and Fertility 87 223–230.
Girolami F, Spalenza V, Benedetto A, Manzini L, Badino P, Abete MC and Nebbia C
(2016) Comparative liver accumulation of dioxin-like compounds in sheep and
cattle: Possible role of AhR-mediated xenobiotic metabolizing enzymes. Science
of The Total Environment.
Grazzini E, Guillon G, Mouillac B and Zingg HH (1998) Inhibition of oxytocin receptor
function by direct binding of progesterone. Nature 392 509–512.
Hart CG, Camacho LE, Swanson KC, Vonnahme KA and Lemley CO (2014) Hepatic
steroid metabolizing enzyme activity during early, mid, and late bovine
pregnancy. Dom. Anim. Endo. 49 31–38.
Hurnik JF, King GJ and Robertson HA (1975) Estrous and related behaviour in
postpartum Holstein cows. Applied Animal Ethology 2 55–68.
Ignarro LJ, Buga GM, Wood KS, Byrns RE and Chaudhuri G (1987) Endotheliumderived relaxing factor produced and released from artery and vein is nitric oxide.
Proceedings of the National Academy of Sciences 84 9265–9269.
Iwano H, Yotsumoto N, Yokota H and Yuasa A (2001) cDNA cloning and expression of
a bovine phenol UDP-glucuronosyltransferase, BovUGT1A6. Life Sciences 68
2131–2139.
Krzymowski T, Kotwica J, Stefańczyk S, Czarnocki J and Dȩbek J (1982) A subovarian
exchange mechanism for the countercurrent transfer of ovarian steroid hormones
in the pig. Journal of Reproduction and Fertility 65 457–465.
60

Lau TM, Kerton DJ, Gow CB and Fairclough RJ (1993) Role of progesterone in the
control of endometrial oxytocin receptors at luteolysis in sheep. J. Reprod. Fert.
98 229–233.
Lemley CO, Wilmoth TA, Tager LR, Krause KM and Wilson ME (2010) Effect of a high
cornstarch diet on hepatic cytochrome P450 2C and 3A activity and progesterone
half-life in dairy cows. Journal of Dairy Science 93 1012–1021.
Lemley CO, Meyer AM, Camacho LE, Neville TL, Newman DJ, Caton JS and
Vonnahme K a. (2012) Melatonin supplementation alters uteroplacental
hemodynamics and fetal development in an ovine model of intrauterine growth
restriction. AJP: Regulatory, Integrative and Comparative Physiology 302 R454–
R467.
Nathan C and Xie Q (1994) Nitric oxide synthases: Roles, tolls, and controls. Cell 78
915–918.
Oliveira JF, Henkes LE, Ashley RL, Purcell SH, Smirnova NP, Rao Veeramachaneni
DN, Anthony R V and Hansen TR (2008) Expression of interferon (IFN)stimulated genes in extrauterine tissues during early pregnancy in sheep is the
consequence of endocrine IFN-t release from the uterine vein. Endocrinology 149
1252–1259.
Ricketts SW (1975) The Technique and Clinical Application of Endometrial Biopsy in
the Mare. Equine Veterinary Journal 7 102–108.
Rosenfeld CR, Killam AP, Battaglia FC, Makowski EL and Meschia G (1973) Effect of
estradiol-17β on the magnitude and distribution of uterine blood flow in
nonpregnant, oophorectomized ewes. Pediat. Res. 7 139–148.
Sarnik S, Hofirek I and Sochor O (2007) Laser Doppler Fluxmetry. Biomed Pap Med Fac
Univ Palacky Olomouc Czech Repub 151 143–146.
Sherman BM and Korenman SG (1975) Hormonal characteristics of the human menstrual
cycle throughout reproductive life. Journal of Clinical Investigation 55 699–706.
Skarzynski DJ, Piotrowska KK, Bah MM, Korzekwa A, Woclawek-Potocka I, Sawai K
and Okuda K (2009) Effects of Exogenous Tumour Necrosis Factor-α on the
Secretory Function of the Bovine Reproductive Tract Depend on Tumour
Necrosis Factor-α Concentrations. Reprod Dom Anim 44 371–379.
Soloff MS, Jeng Y-J, Izban MG, Sinha M, Luxon BA, Stamnes SJ and England SK
(2011) Effects of Progesterone Treatment on Expression of Genes Involved in
Uterine Quiescence. Reproductive Sciences 18 781–797.
Spencer TE, Ott TL and Bazer FW (1996) t-Interferon: pregnancy recognition signal in
ruminants. Proc. Soc. Exp. Biol. Med. 213 215–229.
61

Tasaki Y, Nishimura R, Shibaya M, Lee H-Y, Acosta TJ and Okuda K (2010) Expression
of VEGF and Its Receptors in the Bovine Endometrium Throughout the Estrous
Cycle: Effects of VEGF on Prostaglandin Production in Endometrial Cells.
Journal of Reproduction and Development 56 223–229.
Vasconcelos JLM, Sartori R, Oliveira HN, Guenther JG and Wiltbank MC (2001)
Reduction in size of the ovulatory follicle reduces subsequent luteal size and
pregnancy rate. Theriogenology 56 307–314.
Walters DL, Schams D and Schallenberger E (1984) Pulsatile secretion of
gonadotrophins, ovarian steroids and ovarian oxytocin during the luteal phase of
the oestrous cycle in the cow. Journal of Reproduction and Fertility 71 479–491.
Woclawek-Potocka I, Deptula K, Bah MM, Lee HY, Okuda K and Skarzynski DJ (2004)
Effects of Nitric Oxide and Tumor Necrosis Factor-α on Production of
Prostaglandin F2α and E2 in Bovine Endometrial Cells. Journal of Reproduction
and Development 50 333–340.
Yang JH, Wu MY, Chen CD, Jiang MC, Ho HN and Yang YS (1999) Association of
endometrial blood flow as determined by a modified colour Doppler technique
with subsequent outcome of in-vitro fertilization. Human Reproduction 14 1606–
1610.

62

CHAPTER III
OXYLIPIN PROFILES AND EICOSANOID METABOLIZING ENZYMES IN
BOVINE REPRODUCTIVE TISSUES DURING MATERNAL RECOGNITION OF
PREGNANCY
Abstract
The objective was to determine the effects of pregnancy status on hormone
metabolizing enzymes and oxylipins profiles in corpora lutea (CL) or endometrial
(caruncle; CAR and inter-caruncle; IC) tissues. Cattle were fixed-time artificially
inseminated, and were classified as either exhibiting or not exhibiting estrus based on
estrus activity. Sixteen days after AI, cattle were euthanized and reproductive tracts
collected from 18 non-pregnant and 10 pregnant cows. Activity of cytochrome P450 1A
(CYP1A) and UDP-glucuronosyltransferase (UGT) enzymes were determined using
specific luminogenic substrates, and oxylipin profiles were obtained. Data were analyzed
using MIXED procedure of SAS and model statement included pregnancy status, display
of estrus, and the respective interaction. Activity of CYP1A in the CL and UGT in CAR
and IC was not different (P > 0.05) between pregnant and non-pregnant cattle, as well as
cattle that exhibited or failed to exhibit estrus. In the CL, activity of UGT was decreased
(P < 0.05) in pregnant vs. non-pregnant cattle which exhibited estrus. Corpora lutea of
pregnant cattle contained greater (P < 0.05) concentrations of 9,10-DiHODE, 15,16DiHODE, and 9,10-DiHOME. The decrease in CL UGT activity during pregnancy
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indicates alterations in local hormone metabolism. Moreover, the increase in specific
oxylipins in the CL may indicate novel pathways of eicosanoid metabolism during
maternal recognition of pregnancy.
Introduction
There are a multitude of factors that affect the display of estrus in cattle
(Landaeta-Hernández et al., 2002), but cattle that exhibit estrus yield decreased
pregnancy loss and greater concentrations of serum progesterone (P4) (Pereira et al.,
2016). Production of P4 is the primary function of the CL in livestock species (Kittok et
al., 1983), and a lack of P4 within the uterus creates a less hospitable environment for
successful pregnancies and formation of successful extra-embryonic membranes
(Nephew et al., 1994). Maternal recognition of pregnancy occurs between days 15 and 17
in cattle, which prolongs the lifespan of the CL by the conceptus secreting interferon-tau
(IFNτ) that stimulates the endometrium to secrete pro-embryonic proteins (Bazer, 1992;
Cheng et al., 2007). Moreover, using an in vitro model our laboratory has previously
shown decreased CYP activity following IFNτ exposure (Gilfeather and Lemley, 2016).
However, minimal research has been performed to examine the local steroid metabolism
within the CL. Steroid metabolism occurs in two phases: phase I is performed by
cytochrome P450 (CYP) enzymes, which are further metabolized in phase II by UDPglucuronosyltransferase (UGT). However, some studies have identified CYP enzymes
within the CL (Irusta et al., 2007; Bogan et al., 2008) and uterus of monkeys (Uno et al.,
2006), as well as various reproductive tissues in humans (Yokose et al., 1999; Roman,
2002). Due to the localized and variable control of steroid production based on pregnancy
status and expression of estrus, we hypothesized that pregnant cattle that expressed estrus
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would yield decreased activity of CYP and UGT in CL and endometrial tissues.
Therefore, the first objective was to determine the activity of CYP and UGT within CL,
intercaruncle, and caruncle tissues in pregnant and non-pregnant cattle that have and have
not exhibited signs of estrus.
Oxylipins are a family of lipids that result from biosynthesizing polyunsaturated
fatty acids which result in products such as eicosanoids, epoxides, diols, thromboxanes,
and leukotrienes (Calder, 2010; Gouveia-Figueira et al., 2015; Mavangira and Sordillo,
2017). Production of these oxylipins occurs via CYP enzymes and has been linked to
both pro- and anti-inflammatory responses (Calder, 2010; Zivkovic et al., 2012;
Mavangira and Sordillo, 2017), such as DHA metabolites that include HDPEs, HETEs,
and some EETs. Further metabolism by UGT allows for the inactivation and clearance of
these oxylipins (Heemskerk et al., 2014). Some eicosanoids are important for the
regression of the CL such as PGF2α (Rekawiecki et al., 2008), which allows for the nonpregnant female to begin another follicular phase of the estrous cycle, but other
eicosanoids are important for the maintenance of the CL such as PGE2 to prolong during
gestation and produce P4, especially during maternal recognition of pregnancy period
(Weems et al., 2011). The lack of profiling of oxylipins contained within CL in cattle, as
well as the significant importance of eicosanoid metabolism during maternal recognition
of pregnancy has created a significant gap in knowledge. Moreover, the expression and
activity of CYP and UGT enzymes in the CL could lead to oxylipin metabolite
production and inactivation during maternal recognition of pregnancy. Therefore, we
hypothesized that alterations of localized oxylipins within the CL would be influenced by
pregnancy status during the maternal recognition of pregnancy period.
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Materials and Methods
Animal care and sample collection
Animal care and use were according to protocols approved by the South Dakota
State University Institutional Animal Care and Use Committee. Cattle were allowed to
graze on native pasture (Smooth Brome, Reed Canary, Quack grass, Kentucky Blue, and
Switch Grass) and supplemented with approximately 1.36 kg/head/day of a mixed
concentrate (containing 50% DDGS and 50% corn) and ad libitum access to water.
Twenty-Eight Angus cross cattle (between 3 and 13 yr) had their estrous cycles
synchronized with the CO-Synch fixed-time AI protocol, and estrus activity was
determined from day -2 until AI (day 0). Cattle were classified as either exhibiting or not
exhibiting estrus based on visually determined estrus activity (confirmed with peripheral
concentrations of estradiol). Sixteen days after AI, all cattle were euthanized and
reproductive tracts were collected from 18 non-pregnant and 10 pregnant cows, with
pregnancy determined by presence of an embryo. Corpora lutea (CL) were collected and
weighed at harvest, then snap frozen. Endometrial (caruncle; CAR and inter-caruncle; IC)
tissues contralateral to the CL were collected at harvest and also snap frozen for further
analysis.
Tissue processing
Approximately 200 mg of tissue was placed into a polypropylene tube with 1 mL
potassium phosphate (KPO4) buffer (400 mM, pH = 7.4). Samples were then
mechanically homogenized using the Tissue Tearor (Biospec Products, Bartlesville, OK,
USA) following the manufacturer’s protocol. Tissue homogenates were then centrifuged
at 10,000 × g for 10 min at 4°C. The supernatant was stored at −80°C until enzyme
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assays were conducted. The protein concentration of the supernatant was determined by a
Coomassie Plus (Bradford) protein assay following the manufacturer’s protocol (Thermo
Scientific, Rockford, IL, USA). Following protein analysis, samples were diluted to 4
mg/mL.
CYP enzyme assays
Assay kits for CYP1A, CYP2C, CYP3A, and NADPH regeneration solution were
purchased from Promega Corporation (Madison, WI, USA) and assays conducted
according to Hart and others, 2014, (Hart et al., 2014) with minor adaptations. Briefly,
reconstitution buffer was added to luciferin detection reagent. Luciferin CEE (CYP1A),
luciferin IPA (CYP3A), and luciferin H (CYP2C) were diluted in KPO4 buffer. Tissue
homogenates (30 µg of protein per well) and enzyme-specific luciferin substrate were
added to 96-well opaque white plates in duplicate Plates were then pre-incubated for 10
min (CYP1A), 30 min (CYP3A), or 90 min (CYP2C) at 37°C. Following the incubation,
NADPH regeneration solution was added to each well and plates were incubated for 30
min (CYP1A and CYP2C) at 37°C or 10 min (CYP3A) at room temperature. After the
second incubation, luciferin detection reagent was added to each well and plates were
protected from light and incubated for an additional 20 min at room temperature. Plates
were then placed into a Promega Multi-Plus plate reader and luminescence was
measured. However, no detectable activity of CYP2C or CYP3A in any tissue, as well as
CYP1A activity of uterine tissues were obtained.
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UGT enzyme assay
The UGT assay kit was purchased from Promega Corporation and the assay
performed according to Hart et al. (2014) with minor adaptations. Briefly, uridine
diphosphoglucoronic acid (UDPGA) was added to half the plates to act as reaction wells,
and distilled water was added to the other half as control wells. The UGT reaction
mixture containing UGT multienzyme substrate was then combined with tissue
homogenates (28 µg of tissue protein per well), and the plates were preincubated for 90
min at 37°C. After incubation, detection reagent was added to each of the wells followed
by an incubation period of 20 min at room temperature while protected from light. The
plates were then analyzed using a Promega Multi- Plus plate reader with luminescence
detection mode.
Luteal progesterone assay
Luteal P4 concentrations were determined using radioimmunoassay procedures
based on manufacturer recommendations (MP Biomedicals, Costa Mesa, CA, USA) and
Cline et al., 2016 [30]. Approximately 50 mg of luteal tissue was placed into a 15-mL
conical tube with 5 mL of phosphate buffered saline (PBS). Samples were then
mechanically homogenized using the Tissue Tearor (Biospec Products, Bartlesville, OK,
USA) as previously described. Tissue homogenate samples were centrifuged at 1500 × g
for 15 min at 4°C, then the supernatant was placed into 5-mL polypropylene tube. The
supernatant was vortexed and diluted (1:20) in PBS, which was used to analyze for luteal
P4 concentrations. The inter- and intra-assay coefficients of variation were 3.6 and 4.0%,
respectively. Progesterone concentration is reported as μg of P4 per gram of CL as well as
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total P4 content of CL, which was calculated by multiplying the P4 concentration (µg of
P4 per gram of CL) by the CL weight at harvest.
Luteal oxylipin metabolome assay
Luteal oxylipin metabolome profiles were determined using previously published
procedures based on Yang et al., 2009 (Yang et al., 2009). Only CL from cattle that
exhibited estrus were used for this method of analysis. The formal name and
classification of all oxylipins can be found in supplementary Table 2.
Statistical analysis
Enzyme activities were expressed relative to mg of protein or g of tissue. In
addition, total activity of the CL was calculated by multiplying activity per g of tissue by
CL weight. Data, respective to each tissue, enzyme activity, and CL parameters (CL wt,
µg P4/ gram of CL, and total CL P4) were analyzed using MIXED procedure of SAS and
the model statement included pregnancy status, display of estrus, and the respective
interaction. However, data, respective to CL individual and categorized oxylipin profile
was analyzed using MIXED procedure of SAS and the model statement included
pregnancy status. Pearson correlation coefficients were determined using the CORR
procedure of SAS to analyze the relationships between CL weight, µg of P4/ gram of CL,
total CL P4, and enzyme activity with respect to each tissue. Treatment means were
separated using the PDIFF options of the LSMEANS statement. Least square means and
standard error are reported. Statistical significance was declared at P ≤ 0.05, and
tendencies discussed when P ≥ 0.06 but P ≤ 0.10.
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Results
Effect of estrus and pregnancy on CYP1A and UGT
Activity of CYP1A (RLU/mg of protein, RLU/g of tissue, and total CL) were not
different (P = 0.20) between pregnant and non-pregnant cattle, as well as between cattle
that exhibited or failed to exhibit estrus (P = 0.53) and are displayed in Fig. 8A and 8B,
respectively. Activity of UGT (RLU/g of tissue) among tissues are displayed in Fig. 9. In
CAR and IC, activity of UGT relative to mg of protein and g of tissue were not different
(P ≥ 0.65) between pregnant and non-pregnant cattle, as well as between cattle that
exhibited or failed to exhibit estrus (P ≥ 0.15; Fig. 9A and 9B, respectively). However,
activity of UGT in the CL relative to g of tissue [not shown] and CL total (Fig. 9C) were
decreased (P ≤ 0.05) in pregnant vs. non-pregnant cattle which exhibited estrus, while it
was not different in pregnant vs. non-pregnant cattle that did not exhibit estrus.
Luteal weight, progesterone, and oxylipins
Corpora lutea weights at the time of harvest were not different across all groups
(4.37 ± 0.17 g). Luteal concentrations of P4, µg /g CL, were not different across all
groups (50.84 ± 5.23 µg /g CL). Also, total CL P4, was not different across all groups
(222.98 ± 22.48 µg). Concentrations of circulating serum P4 were not different across all
groups (4.05 ± 0.31 ng/mL). A detailed list of the individual oxylipins found in the CL
tissues are found in Table 3, and categories of oxylipins are found in Table 4. Corpora
lutea from pregnant cattle contained greater (P ≤ 0.05) concentrations of 9,10-DiHODE,
15,16-DiHODE, and 9,10-DiHOME as compared to non-pregnant cattle. Corpora lutea
from pregnant cattle tended (P = 0.08) to contain lesser concentration of 13-oxo-ODE,
while CL from pregnant cattle tended (P = 0.06) to contain greater concentration of
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19,20-DiHDPE as compared to non-pregnant cattle. No differences (P = 0.21) were
observed between pregnant and non-pregnant concentrations of total oxylipins in CL.
Discussion
One of the more interesting findings from this research was a decrease in Phase II
UGT enzyme activity in the CL of pregnant vs non-pregnant cattle. These UGT enzymes
are involved in conjugating lipophilic molecules, such as steroids and eicosanoids, for
more easy excretion via the urinary system. This experiment exposed the differential
activity of UGT between intercaruncle and caruncle tissues; however, no differences
were observed between cattle that expressed estrus or not and cattle that were pregnant or
not in intercaruncle and caruncular activity of UGT. Data from all cattle in the current
study tended to exhibit a negative correlation (r = -0.36, P = 0.06) between UGT activity
in caruncular tissue (RLU/g of tissue) and ng of P4/g of CL. In addition to activity of
UGT in uterine tissues, this study examined the activity of UGT in CL tissues. This
activity of UGT in CL was greatest in cattle that expressed estrus and were non-pregnant
as compared to non-pregnant cattle that failed to express estrus and pregnant cattle that
expressed estrus. A significant negative correlation (r = -0.50, P = 0.02) existed between
CL weight and UGT activity in the CL (RLU/mg of protein), which indicates that CL
with lesser weight have greater activity of UGT as compared to their heavier
counterparts. However, local UGT activity within the CL did not correlate with the P4
content of the CL in this study and therefore is not influencing the P4 content of the CL.
The presence of the phase I steroid metabolizing enzyme, CYP1A, indicates
localized metabolism of steroids within the CL of cattle. Contrary to the current study,
CYP2C and 3A have been observed in the CL of rhesus monkeys (Irusta et al., 2007), but
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these enzymes were not detectable in the CL collected from cattle. Activity of CYP1A in
CL tissue was not different between cattle that expressed estrus or not and cattle that
were pregnant. Previous research in our laboratory (Gilfeather and Lemley, 2016) have
indicated decreased CYP1A activity in bovine endometrial epithelial cells treated with
IFNτ as well as oxytocin and IFNτ as compared to those cells treated with oxytocin and
vehicle control. This was the first report of decreased steroid metabolizing enzyme
activity following in vitro IFNτ treatment which indicates that during the maternal
recognition of pregnancy, the IFNτ secreted from the conceptus induces a localized
decrease of steroid and eicosanoid metabolism. This in vitro work does not recapitulate
the current in vivo analysis, due to the inability to detect CYP1A in endometrial tissues.
This may be due to external factors affecting the biological functions that affect the
activity of the enzymes. Neither pregnancy status nor expression of estrus was different
with regards to CL weight, µg of P4/g of CL, and total CL P4.
Due to the decreased activity of UGT within the CL of pregnant cattle that
expressed estrus and our hypothesis that pregnant cattle that expressed estrus would yield
lesser activity of CYP and UGT within the CL, we examined the profile in the CL. A
majority of the oxylipins characterized were not different between pregnant and nonpregnant cattle in the present study. Octadecadienoic acids (ODE), 15,16-DiHODE and
9,10-DiHODE, were greater in CL from pregnant cattle as compared to CL from nonpregnant cattle. However, 13-oxo-ODE tended to be lesser in pregnant CL as compared
to the non-pregnant CL. These ODE are primarily derived from omega fatty acids (omega
3, 6, and 9), specifically α-linoleic acid, linoleic, and oleic acid (Calder, 2010; Chang et
al., 2012; Gouveia-Figueira et al., 2015) and have been identified in human serum and
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plasma, hepatic, and intestinal microsomes (Little et al., 2004; Zivkovic et al., 2012;
Gouveia-Figueira et al., 2015; Berkecz et al., 2017), which are concurrent with the
locations of CYP and UGT (Chun et al., 1999; Yokose et al., 1999; Khan and Khan,
2013). Supplementation of omega fatty acids have decreased the inflammatory oxylipins
(Zivkovic et al., 2012; Bruins et al., 2013), increased density of omega 3 fatty acids in the
blood (White et al., 2012), and increase in ODE that have been noted to be involved with
cellular proliferation (Reynolds et al., 2006).
Epoxide hydrolase metabolites 9,10-DiHOME and 19,20-DiHDPE were greater in
CL from pregnant cows as compared to CL from non-pregnant cattle in this study.
Concentrations of 9,10-DiHOME have been differentially expressed in the cow brain,
heart, and liver, with the liver containing the greatest quantity and the brain with the least
(Gouveia-Figueira and Nording, 2015b). Contrary to the ODE oxylipins mentioned
above, 9,10-DiHOME and 19,20-DiHDPE decreased in serum when supplemented with
omega fatty acids (Zivkovic et al., 2012). Supplementation of cancer cells with
docosahexaenoic acid (DHA) were converted to 19,20-DiHDPE which decreased
angiogenic factors, tumor growth, and endothelial cell migration; however, 19,20DiHDPE in healthy adipose tissue from humans have been noted to suppress
inflammation (Bruins et al., 2013; Heemskerk et al., 2014). The increase of 19,20DiHDPE in CL from pregnant cattle as compared to non-pregnant animals could indicate
the suppression of inflammation that luteolysis induces; however, further investigations
are needed to prove this pathway.
Activity of UGT in this experiment was observed within intercaruncle and
caruncle tissues with no differences observed between cattle that expressed estrus or not
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nor cattle that were pregnant or not. This implies that deactivation and clearance of the
eicosanoids and steroid metabolites that are produced could be acted upon via UGT.
Also, the identification of local metabolism of steroids could allow researchers to develop
a more efficient estrous synchronization protocol or even a therapy for those cattle that
are reproductively incompetent. The detection of activity of UGT in CL indicates that
there is localized metabolism of steroids and eicosanoids within the CL, and were
differentially expressed between pregnant and non-pregnant cattle as well as cattle that
expressed or failed to express estrus. Furthermore, characterization of oxylipins in CL of
cattle that expressed estrus in this study allows for further research to be conducted to
obtain a greater understanding of the pro- and anti-inflammatory and embryonic factors
that affect the CL and could affect the health, production, and longevity of this transient
organ to maintain pregnancy.
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Table 2

Full oxylipin profile name within CL tissues of cattle at day 16 post
insemination and the classification of each in pmol per gram of CL tissue ±
standard error.

Oxylipin
abbreviation
10(11)-EpDPE
11(12)-EpETE
11(12)-EpETrE
11,12-DiHETE
11,12-DiHETrE
12(13)-EpODE
12(13)-EpOME
12,13-DiHODE
12,13-DiHOME
13,14-DiHDPE
13-HODE
13-oxo-ODE
14(15)-EpETE
14(15)-EpETrE
14,15-DiHETE
14,15-DiHETrE
15,16-DiHODE
15-HEPE
15-oxo-ETE
16,17-DiHDPE
17(18)-EpETE
17,18-DiHETE
19(20)-EpDPE
19,20-DiHDPE
5(6)-EpETrE
6-keto-PGF1a
7(8)-EpDPE
8(9)-EpETE
8-HEPE

Full oxylipin name

Classification

10,11-epoxy Docosapentaenoic Acid
11,12-epoxy-5Z,8Z,14Z,17Z-eicosatetraenoic acid
11,(12)-epoxy-5Z,8Z,14Z-eicosatrienoic acid
11,12-dihydroxy-5Z,8Z,14Z,17Z-eicosatetraenoic
acid
11,12-dihydroxy-5Z,8Z,14Z-eicosatrienoic acid
12(13)-epoxy-9Z,15Z-octadecadienoic acid
12(13)epoxy-9Z-octadecenoic acid
12,13-dihydroxy-9Z,15Z-octadecadienoic acid
12,13-dihydroxy-9Z-octadecenoic acid
13,14-dihydroxy-4Z,7Z,10Z,16Z,19Zdocosapentaenoic acid
13-hydroxy-9Z,11E-octadecadienoic acid
13-oxo-9Z,11E-octadecadienoic acid
14,15-epoxy-5Z,8Z,11Z,17Z-eicosatetraenoic acid
14(15)-epoxy-5Z,8Z,11Z-eicosatrienoic acid
14,15-dihydroxy-5Z,8Z,11Z,17Z-eicosatetraenoic
acid
14,15-dihydroxy-5Z,8Z,11Z-eicosatrienoic acid
15,16-dihydroxy-9Z,12Z-octadecadienoic acid
15-hydroxy-5Z,8Z,11Z,13E,17Z-eicosapentaenoic
acid
15-oxo-5Z,8Z,11Z,13E-eicosatetraenoic acid
16,17-dihydroxy-4Z,7Z,10Z,13Z,19Zdocosapentaenoic acid
17,18-epoxy-5Z,8Z,11Z,14Z-eicosatetraenoic acid
17,18-dihydroxy-5Z,8Z,11Z,14Z-eicosatetraenoic
acid
19,20-epoxy-4Z,7Z,10Z,13Z,16Zdocosapentaenoic acid
19,20-dihydroxy-4Z,7Z,10Z,13Z,16Zdocosapentaenoic acid
5,6-epoxy-8Z,11Z,14Z-eicosatrienoic acid
6-oxo-9α,11α,15S-trihydroxy-prost-13E-en-1-oic3,3,4,4-acid
(4Z)-6-[3-(2Z,5Z,8Z,11Z)-2,5,8,11tetradecatetraen-1-yl-2-oxiranyl]-4-hexenoic acid
8,9-epoxy-5Z,11Z,14Z,17Z-eicosatetraenoic acid
8-hydroxy-5Z,9E,11Z,14Z,17Z-eicosapentaenoic
acid
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EH
EET
EET
HETE
EET
ODE
EH
ODE
EH
HDPE
ODE
ODE
EET
EET
HETE
EET
ODE
mFA
Leukotoxin
HDPE
EET
HETE
EH
EH
EET
Prostaglandin
EH
EET
mFA

Table 2 (continued)
9(10)-EpODE
9(10)-EpOME
9,10,13TriHOME
9,10-DiHODE
9,10-DiHOME
9,12,13TriHOME
9-HODE
9-HOTrE
LTB5
PGD2

Table 3

9(10)-epoxy-12Z,15Z-octadecadienoic acid
9(10)epoxy-12Z-octadecenoic 9,10,12,13-acid

Leukotoxin
Leukotoxin

9,10,13-Trihydroxy-11-octadecenoic acid

ODE

9,10-dihydroxy-12Z,15Z-octadecadienoic acid
9,10-dihydroxy-12Z-octadecenoic-9,10,12,13-acid

ODE
EH

9,12,13-Trihydroxy-10-octadecenoic acid

ODE

9-hydroxy-10E,12Z-octadecadienoic-9,10,12,13acid
9-hydroxy-10E,12Z,15Z-octadecatrienoic acid
Leukotriene B5; 5S,12S-dihydroxy6Z,8E,14Z,17Z-eicosapentanenoic acid
Prostaglandin D2; 9α,15S-dihydroxy-11-oxoprosta-5Z,13E-dien-1-oic acid

mFA
mFA
Leukotoxin
Prostaglandin

Individual oxylipin profile within CL tissues of cattle at day 16 post
insemination comparing pregnancy status in pmol per gram of CL tissue ±
standard error.

Oxylipin (pmol/g tissue)
10(11)-EpDPE
11(12)-EpETE
11(12)-EpETrE
11,12-DiHETE
11,12-DiHETrE
12(13)-EpODE
12(13)-EpOME
12,13-DiHODE
12,13-DiHOME
13,14-DiHDPE
13-HODE
13-oxo-ODE
14(15)-EpETE
14(15)-EpETrE
14,15-DiHETE
14,15-DiHETrE
15,16-DiHODE
15-HEPE

Pregnancy Status
Non-Pregnant
Pregnant
6.98 ± 1.97
6.12 ± 3.97
41.79 ± 7.92
47.84 ± 30.43
300.95 ± 63.02
350.32 ± 217.82
1.11 ± 0.10
1.14 ± 0.15
12.99 ± 2.31
13.72 ± 1.60
17.25 ± 2.42
18.39 ± 8.93
147.16 ± 28.93
148.88 ± 79.14
2.13 ± 0.29
3.19 ± 0.63
35.86 ± 1.98
47.55 ± 6.50
1.07 ± 0.26
1.30 ± 0.13
309.05 ± 253.02
60.03 ± 20.32
35.74 ± 14.61
15.59 ± 7.32
33.60 ± 7.30
43.04 ± 25.86
250.56 ± 60.12
296.31 ± 174.64
18.54 4.51
21.99 ± 4.74
90.90 ± 7.65
109.39 ± 23.76
5.82 ± 0.73
8.53 ± 0.91
4.33 ± 0.46
4.77 ± 0.67
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P-Value
0.16
0.21
0.21
0.88
0.80
0.28
0.16
0.16
0.12
0.21
0.77
0.08
0.21
0.21
0.61
0.48
0.04
0.60

Table 3 (continued)
15-oxo-ETE
16,17-DiHDPE
17(18)-EpETE
17,18-DiHETE
19(20)-EpDPE
19,20-DiHDPE
5(6)-EpETrE
6-keto-PGF1a
7(8)-EpDPE
8(9)-EpETE
8-HEPE
9(10)-EpODE
9(10)-EpOME
9,10,13-TriHOME
9,10-DiHODE
9,10-DiHOME
9,12,13-TriHOME
9-HODE
9-HOTrE
LTB5
PGD2
Total

Table 4

262.95 ± 232.97
32.29 ± 6.44
61.68 ± 10.05
11.35 ± 0.99
10.13 ± 2.54
4.75 ± 0.36
1067.25 ± 266.23
12.03 ± 4.02
90.80 ± 27.79
37.05 ± 5.96
122.77 ± 35.56
41.16 ± 7.02
148.59 ± 32.90
10.60 ± 3.18
0.48 ± 0.09
4.75 ± 0.36
18.50 ± 5.81
72.77 ± 43.65
20.96 ± 17.34
2.10 ± 0.40
2.15 ± 0.80
3358.30 ± 777.69

14.82 ± 2.17
38.30 ± 12.06
65.00 ± 38.95
10.61 ± 1.03
9.11 ± 5.61
6.38 ± 0.22
1239.26 ± 815.08
35.56 ± 13.87
78.73 ± 51.00
37.68 ± 23.72
214.77 ± 154.67
40.85 ± 19.65
135.94 ± 67.05
11.85 ± 1.37
0.72 ± 0.08
6.38 ± 0.22
21.04 ± 2.23
31.01 ± 7.78
2.25 ± 0.44
1.62 ± 0.32
5.66 ± 3.12
3208.74 ± 1691.26

0.36
0.88
0.21
0.62
0.21
0.06
0.21
0.11
0.28
0.11
0.55
0.28
0.28
0.73
0.05
0.003
0.69
0.77
0.28
0.37
0.88
0.21

Categorical oxylipin profile within CL tissues of cattle at day 16 post
insemination comparing pregnancy status. Concentration in pmol per gram
of CL tissue ± standard error.
Pregnancy Status

Oxylipin Category
(pmol/g tissue)
Prostaglandin
HETE
EH
HDPE
EET
mFA
Leukotoxin
ODE

Non-Pregnant

Pregnant

P-Value

14.18 ± 4.81
30.99 ± 5.25
300.85 ± 58.23
33.36 ± 6.67
1896.77 ± 416.83
227.80 ± 61.01
454.80 ± 232.45
399.57 ± 264.09

41.22 ± 16.47
33.74 ± 5.53
300.15 ± 133.67
39.60 ± 12.15
2202.56 ± 1314.83
258.91 ± 156.13
193.23 ± 88.04
139.33 ± 27.52

0.16
0.73
0.21
0.88
0.21
0.36
0.11
0.65

77

Figure 8

Activity of CYP1A in CL tissue in cattle based on pregnancy status and
estrus expression.

Figure 9

Activity of UGT in caruncle, intercaruncle, and CL tissues in cattle based on
pregnancy status and estrus expression. Least square means with different
letters within row represent significant differences (P ≤ 0.05).
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CHAPTER IV
CHARACTERIZATION OF FETAL LIVER AND PLACENTOME STEROID AND
EICOSANOID METABOLIZING ENZYMES IN HEIFERS SUPPLEMENTED WITH
MELATONIN
Abstract
Melatonin supplementation influences the metabolism of steroids and
eicosanoids. The objective was to examine fetal liver and placental steroid and eicosanoid
enzyme activity during maternal melatonin supplementation. Commercial beef heifers (n
= 12) were bred via AI and delegated to receive two, 24 mg sub-dermal melatonin
implants (MEL; n = 6) or act as part of a non-implant control group (CON; n = 6).
Treatments were administered at d 180, 210, and 240 of gestation. Heifers underwent
Caesarian removal of the fetus at 243 ± 2 d of gestation to harvest fetal liver and
placental tissues. The placental samples were collected and separated into maternal
(caruncle; CAR) and fetal (cotyledon; COT) portions. Cytochrome P450 1A (CYP1A),
2C (CYP2C), 3A (CYP3A), and uridine 5’-diphospho-glucuronosyltransferase (UGT)
activities were determined via luminogenic substrates. Activities were expressed per mg
of protein, and data were analyzed, using the Wilcoxon rank sum test, with treatment,
fetal sex, and the interaction thereof in the model. Statistical significance was declared at
P ≤ 0.05. Maternal and fetal morphometric measurements were not different between
treatments. Activity of CYP1A and UGT in fetal liver was greater from dams treated with
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MEL as compared to CON. Activity of CYP3A was not different between treatments
while activity of CYP2C was not detected in fetal liver tissues. Activity of CYP1A,
CYP2C, and UGT were not different between treatments in CAR tissues while activity of
CYP3A was not detected in CAR tissues. Activity of CYP1A and UGT were not
different between treatments in COT tissues while activity of CYP2C and CYP3A was
not detected in COT tissues. In conclusion, melatonin supplementation increased CYP1A
and UGT in fetal liver; however, hormone metabolizing enzymes of the placenta were not
different between treatments. Increased activity of CYP1A and UGT in fetal liver during
maternal melatonin supplementation indicates an increase in steroid and eicosanoid
metabolism during the fetal period.
Introduction
Increasing the viability and ultimately profitability of calves is the goal of all
producers, and research has led to applying various therapies to do so. Therapeutic
supplements applied to dams have been utilized to impact future reproductive capabilities
of the offspring. Reduced maternal nutrition has decreased cellular proliferation in fetal
gonads and longer attainment of puberty in both cattle and sheep (Funston et al., 2010).
Adequate maternal nutrition has yielded greater lamb and calf weights, which has been
associated with more offspring being more vigorous and having a better chance of
survival (Godfrey, 2002; Wu et al., 2004; Meyer et al., 2010; Meyer et al., 2013).
Supplementation of melatonin to dams has been observed to influence not only placental
characteristics, but also affects the fetal organs in both sheep and cattle (Forcada et al.,
1995; Lemley et al., 2012; Lemley et al., 2013a; Eifert et al., 2015). Melatonin is a
neurohormone secreted primarily by the pineal gland that serves several physiological
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functions in the body including reproductive cyclicity in seasonal breeding animals and
influences pubertal development (Reiter et al., 2006; Pandi-Perumal et al., 2008; Russel
J. Reiter et al., 2009).
Supplementation of melatonin to ewes negated the effects of nutrient restriction as
compared to those ewes that were not nutrient restricted as measured by the number of
viable embryos per CL and overall pregnancy rates (Vázquez et al., 2013). Dietary
enhancement of melatonin throughout the last third of gestation increased uterine blood
flow, heart rate, and total antioxidant capacity, but it decreased maternal serum estradiol17β and P4 concentrations (Brockus et al., 2016b). Melatonin supplementation to bovine
endometria cells has also increased the activity of phase I and II enzymes that metabolize
steroids and eicosanoids as compared to control treatments (Brockus et al., 2016b). These
phase I enzymes include cytochrome P450 (CYP) including CYP1A and CYP3A that
metabolizes estrogens and several eicosanoids, as well as CYP2C and CYP3A which
metabolizes progestins and several eicosanoids (Canby-Hagino and Thompson, 2005).
The primary phase II enzyme responsible for further metabolism of phase I metabolites is
UDP-glucoronosyltransferase (UGT) in order to allow for clearance of these molecules
(Kim et al., 1997). This leads to the objective to examine fetal liver and placental steroid
and eicosanoid enzyme activity during maternal melatonin supplementation in the last
third of gestation. We hypothesized that fetal liver and placental tissues from melatonin
treated dams would contain greater activity of steroid and eicosanoid metabolizing
enzymes.
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Materials and Methods
Animal care and treatments
Animal care and use was conducted according to protocols approved by the
Mississippi State University Institutional Animal Care and Use Committee. Twelve Angus cross heifers were synchronized using a modified 7-day CO-Synch + CIDR
protocol. Briefly, a 2 ml, i.m. injection of GnRH (Factrel, Fort Dodge Animal Health,
Fort Dodge, Iowa, USA) was administered, and a cattle CIDR (Eazi-Breed™ CIDR®
Cattle Insert, Zoetis, Parsippany, NJ, USA) was inserted for 7 days, upon CIDR removal
cattle were administered a 5 ml, i.m. injection of Lutalyse (dinoprost injection, Zoetis,
Parsippany, NJ, USA), and estrus was detected in 60 ± 6 hrs. Heifers were AI to the same
bull and enrolled in the study upon pregnancy verification via rectal ultrasonography on d
127. Heifers were designated to one of two treatments, a control group (CON; n = 6) that
acted as a placebo non-implant group, or a melatonin treatment group that would receive
two, 24 mg sub-dermal implants (Melatonin Implants LLC, Conroe, TX, USA; MEL; n =
6). Heifers underwent Cesarean removal of the fetus at 243 ± 2 d of gestation where a
single placentome was harvested.
Sample collection and treatment application
Heifers designated to the MEL group received two, 24 mg sub-dermal melatonin
implants in the backside of the ear using a syringe implant applicator (Melatonin
Applicator, Melatonin Implants LLC, Conroe, TX, USA), alternating implant sides each
application period. Heifers designated to the CON group were stuck with syringe implant
applicator to simulate the mode of receiving an implant. Sampling and treatment
application began on d 180 of gestation and were applied again on d 210 and 240 of
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gestation. Each implant was designed to supply sufficient amounts of melatonin for 30
days. The entire treatment period was expected to last for the final 90 days of gestation.
Immediately prior to Cesarean section blood samples were collected via coccygeal
venipuncture and heifers were weighed. At 243 ± 2 d of gestation heifers underwent
Cesarean section removal of the fetus via standing left paralumbar celiotomy. Cattle were
initially sedated (5 mg butorphanol, 10 mg xylazine, and 20 mg ketamine) and were
injected with lidocaine (100 mL total) in an inverted L-shape to ensure local anesthesia.
An incision was made vertically in the middle of the paralumbar fossa, starting
approximately 10 cm ventral to the transverse processes of the lumbar vertebrae and
continuing ventrally, far enough to allow removal of the calf.
Just prior to complete removal of the calf the umbilical cord was occluded with
Kelly forceps to ensure no blood loss. Once the calf was removed, a single placentome
was collected approximately 5 cm from the incision site. Incisions were then closed and
heifers were administered 50 mL Liquamycin® LA-200® (oxytetracycline injectable
solution; Zoetis Services LLC., Parsippany, NJ, USA) and 10 mL Banamine (flunixin
meglumine, Merck & Co., Inc., Kenilworth, NJ, USA) i.m. Calves were weighed and
euthanized via jugular exsanguination and fetal blood was collected at this time. Carcass
weight was collected which includes head, hide, and carcass weights that does not
include internal organs. The fetal liver was collected and weighed. Concurrently, the
placentome was separated into maternal (caruncle; CAR) and fetal (cotyledon; COT)
portions and snap frozen in liquid nitrogen.
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Blood and tissue processing
Serum tubes were incubated at room temperature for at least 30 min prior to being
centrifuged and plasma tubes were inverted several times and held on ice for
transportation. Centrifugation was performed at 4°C for 15 min at 10,000 x g. Serum was
harvested and subsequently stored at -80°C until assayed. Approximately 100 mg of
tissue was placed into a polypropylene tube with 1 mL of potassium phosphate (KPO4)
buffer (400 mM, pH = 7.4). Samples were then mechanically homogenized using the
Tissue Tearor (Biospec Products, Bartlesville, OK, USA) following the manufacturer’s
protocol. Tissue homogenate samples were placed into microcentrifuge tubes and then
centrifuged at 10,000 × g for 10 min at 4°C. The supernatant was stored at −80°C until
enzyme assays were conducted. The protein concentration of the supernatant was
determined by a Coomassie Plus (Bradford) protein assay following the manufacturer’s
protocol (Thermo Scientific, Rockford, IL, USA).
Serum P4 assay
Serum P4 concentrations were determined using radioimmunoassay procedures
based on manufacturer recommendations (MP Biomedicals, Costa Mesa, CA, USA) and
Cline et al., 2016. Briefly, serum samples and standards were vortexed and 100 µL was
pipetted into each respective coated tube, in duplicate. Following standard and serum
sample allocation 1.0 mL of P4-I125 was pipetted into each tube and briefly vortexed
before incubating at 37°C for 2 hours. All standard and sample tubes were decanted and
tubes were counted in a Cobra II gamma counter (Packard, Meriden, CT, USA). The
intra-assay coefficient of variation is 5.6%, and concentration of P4 is expressed as
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ng/mL. Serum P4 concentrations were determined only within the maternal serum due to
the fetal serum not containing enough P4 to yield detectable readings.
CYP enzyme assays
Assay kits for CYP1A, CYP2C, and CYP3A, and NADPH regeneration solution
were purchased from Promega Corporation (Madison, WI, USA) and assays conducted
according to Hart et al. (2014) with minor adaptations. Briefly, reconstitution buffer was
added to luciferin detection reagent. Luciferin CEE (CYP1A), luciferin IPA (CYP3A),
and luciferin H (CYP2C) were diluted in KPO4 buffer. Tissue homogenates (30 µg of
protein per well) and enzyme- specific luciferin substrate was added to 96-well plates in
duplicate. Plates were then preincubated for 10 min (CYP1A), 30 min (CYP3A), or 90
min (CYP2C) at 37°C. Following the incubation, NADPH regeneration solution was
added to each well and plates were incubated for 30 min (CYP1A and CYP2C) at 37°C
or 10 min (CYP3A) at room temperature. After the incubation, luciferin detection reagent
was added to each well and plates were protected from light and incubated for an
additional 20 min at room temperature. Plates were then placed into a Promega MultiPlus plate reader and luminescence was measured.
UGT assay
The UGT assay kit was purchased from Promega Corporation and the assay
performed according to Hart et al. (2014) with minor adaptations. Briefly, uridine
diphosphoglucoronic acid (UDPGA) was added to half the plates to act as reaction wells,
and distilled water was added to the other half as control wells. The UGT reaction
mixture containing UGT multienzyme substrate was then combined with tissue
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homogenates (28 µg of tissue protein per well), and the plates were preincubated for 90
min at 37°C. After incubation, detection reagent was added to each of the wells followed
by an incubation period of 20 min at room temperature while protected from light. The
plates were then analyzed using a Promega Multi- Plus plate reader with luminescence
detection mode.
Statistical analysis
The MIXED procedure of SAS (SAS Inst. Inc, Cary, NC, USA) was used to test
the effect of treatment within each tissue type. Fetal body weight was used as a covariant
and removed from the model if P-value of > 0.20. Treatment means were separated using
the PDIFF options of the LSMEANS statement. Least square means and standard error
are reported. Pearson correlation coefficients were determined using the CORR
procedure of SAS to analyze the relationships between organ weights, concentration of
serum P4, and enzyme activity with respect to each tissue. Statistical significance was
declared at P ≤ 0.05, and tendencies discussed when P ≥ 0.06 but P ≤ 0.10.
Results
Effect of treatment on P4 and weight parameters
Concentrations of circulating serum P4 were not different (P = 0.47) between
MEL treated dams and CON treated dams (4.65 and 3.83 ± 0.77 ng/mL, respectively).
Effects of the supplementation of subdermal melatonin during the last third of gestation
on body and organ weights are outlined in Table 5. Melatonin supplementation for 90 d,
during the last third of gestation, had no effect on maternal BW (P = 0.27). Fetuses
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collected from dams that were treated with melatonin or control dams had no effect on
body wt (P = 0.51), carcass wt (P = 0.53), or liver wt (P = 0.70).
Activity of CYP and UGT enzymes in fetal liver and placentome components
Enzymatic activity of CYPs and UGT in fetal liver tissues are outlined in Table 6.
Activity of CYP1A (RLU/ [min*mg protein]) was greater in fetal livers collected from
dams that were supplemented with melatonin. However, activity of CYP1A (RLU/
(min/gram) was not different in fetal liver. Activity of CYP2C was not detected in the
fetal liver. Activity of CYP3A (RLU/ [min*mg protein] and RLU/ [min/gram]) in fetal
liver was not different (P = 0.20) between fetuses that were collected from control or
melatonin treated dams. Activity of UGT (RLU/ [min*mg protein] and RLU/
[min/gram]) was greater in fetal livers from dams that were supplemented with melatonin
versus control. Enzymatic activity of CYPs and UGT in placentome tissues are outlined
in Table 7. Activity of CYP1A, CYP2C, and UGT (RLU/ [min*mg protein] and RLU/
[min/gram]) in caruncular tissue was not different (P > 0.05) between control or
melatonin treated dams. Activity of CYP1A and UGT (RLU/ [min*mg protein] and
RLU/ [min/gram]) in cotyledonary tissue was not different (P > 0.05) between control or
melatonin treated dams. Caruncular tissue did not express activity of CYP3A, while
cotyledonary tissue did not express activity of CYP1A and UGT.
Discussion
Application of melatonin in the current study did not increase dam or fetal
weights, and previous research in our lab demonstrated similar birth weights in cattle
orally supplemented with melatonin. However, the calves born to melatonin
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supplemented dams increased in BW and heart girth by 9 wk of age compared to calves
born to control dams (Brockus et al., 2016a). Supplementation of melatonin to ewes
during the middle third of gestation failed to change fetal carcass weights (Lemley et al.,
2013b), similar to the current study. This lack of increase in fetal weight and
morphometric measurements indicates that supplementation of melatonin to dams,
especially heifers, will not increase the likelihood of dystocia due to increased fetal size.
Activity of CYP1A (RLU/ mg protein) was increased in fetal liver tissues
collected from MEL treated dams in the current study. Supplementation of melatonin to
pregnant mice and rats assisted in mitigating the effects of inflammatory challenges
within the fetal liver based on the concentrations of TNFα, IL-6, and IL-1β, which are
inflammatory mediators (Perez et al., 2007; Xu et al., 2007). This indicates that melatonin
supplementation to the dams positively affects the abilities of the fetus to overcome
adverse biological processes. Activity of CYP2C was not detected within fetal liver in the
current experiment, which is in agreement with previous research (Lekatz et al., 2015).
This indicates that there must be a signal to the liver to activate this enzyme to begin
metabolizing hormones and xenobiotics. Whereas activity of CYP3A was not different
between treatments. Activity of UGT in fetal liver tissues was 2.25-fold greater (P <
0.05) in fetuses collected from melatonin treated dams as compared to control. This
increase could indicate that the fetus’s liver is already beginning to inactivate not only
steroids, but also eicosanoids. In addition to melatonin supplementation increasing fetal
liver UGT activity, increased metabolizable protein administered to ewes during
gestation increases UGT activity within fetal liver tissues (Lekatz et al., 2015).
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Activity of CYP1A, CYP2C, and UGT in caruncular tissues was not different
between treatments, but the CYP2C activity within the caruncle was negatively correlated
(r = -0.60, P = 0.05) with fetal weight. Activity of CYP3A was not detected within
caruncle or cotyledon tissues in the current experiment while activity of CYP2C was not
detected within cotyledon tissues in the current experiment. Activity of CYP1A and UGT
in cotyledon tissues was not different between treatments. These findings do not support
our hypothesis and are not correlated to the maternal serum P4.
Supplementation of melatonin to pregnant animals could provide for a viable
method to increase post-natal weight gain and help prevent oxidative stress. Melatonin
supplementation did not alter organ morphometric measurements at d 240 of gestation
which indicates that this supplement may not increase the incidence of dystocia due to
increased calf birth weights. Increased CYP1A and UGT enzyme activity within fetal
liver implies that the fetus is preparing itself for greater metabolism of steroids,
eicosanoids, and xenobiotics. However, melatonin’s ability to increase blood flow and
alterations in-utero have been linked to future health complications and future research is
needed to extrapolate these consequences. Melatonin supplementation did not affect the
activity of CYP or UGT as hypothesized and this could indicate that melatonin does not
alter the typical metabolism performed by the caruncle and cotyledon during gestation.
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Table 5

Measurements of heifer body weight, fetal body weight, and fetal organ
weight following maternal melatonin (MEL) supplementation on d 180, 210,
and 240 of gestation.

Dependent variable
CON
MEL
SE
P-Value
Heifer
BW, kg1
511.8
525.3
8.0
0.27
Fetal
BW, kg2
24.0
22.9
1.2
0.51
3
Carcass wt, kg
18.9
18.0
1.0
0.53
Liver wt, kg
0.50
0.48
0.03
0.70
g/kg of ECW
0.026
0.027
0.001
0.79
Least square means and pooled standard error is reported. Probability values (P-values)
are indicated.

Table 6

Activity of cytochrome P450 1A (CYP1A), cytochrome P450 3A (CYP3A),
and uridine 5’diphosphate-glucuronosyltransferase (UGT) in fetal liver
tissue of heifers treated with melatonin (MEL) or control (CON) at 180,
210, and 240 d of gestation.

Dependent variable

CON

MEL

P-Value

109.6 ± 54.9a

207.4 ± 50.3b

0.03

RLU/(min/gram) x 102
CYP3A
RLU/(min*mg protein) x102

39.1 ± 21.5

57.3 ± 13.5

0.22

99.7 ± 54.4

288.4 ± 107.0

0.20

RLU/(min/gram) x 104
UGT
RLU/(min*mg protein) x 104

34.7 ± 21.4

87.7 ± 35.9

0.20

68.2 ± 8.2a

153.3 ± 21.8b

0.0002

Fetal liver
CYP1A
RLU/(min*mg protein)

6

a

b

RLU/(min/gram) x 10
22.4 ± 4.0
42.4 ± 5.9
0.03
Least square means with different letters within row represent significant differences (P ≤
0.05). Activity is reported in relative light units (RLU) per mg of protein and per gram of
tissue. Dam treatment is separated with standard errors for each, and probability values
(P-values) are indicated.
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Table 7

Activity of cytochrome P450 1A (CYP1A), cytochrome P450 2C (CYP2C),
and uridine 5’diphosphate-glucuronosyltransferase (UGT) in caruncle and
cotyledon tissues collected from cattle that were treated with either subcutaneous melatonin implants (MEL) or control group (CON) at 180, 210,
and 240 d of gestation.

Dependent variable
CON
MEL
P-Value
Caruncle
CYP1A
RLU/(min*mg protein) x 102
30.3 ± 9.6
42.1 ± 20.4
0.88
4
RLU/(min/gram) x 10
10.1 ± 3.0
16.1 ± 8.1
0.88
CYP2C
RLU/(min*mg protein)
89.2 ± 15.3
74.7 ± 12.4
0.73
2
RLU/(min/gram) x 10
29.3 ± 3.9
27.8 ± 4.5
0.87
UGT
RLU/(min*mg protein) x 104
20.1 ± 6.2
12.7 ± 1.9
1.00
RLU/(min/gram) x 105
47.8 ± 8.4
42.1 ± 9.1
1.00
Cotyledon
CYP1A
RLU/(min*mg protein)
208.3 ± 30.8 562.5 ± 311.5
0.39
RLU/(min/gram) x 103
7.2 ± 1.2
22.0 ± 13.2
0.49
UGT
RLU/(min*mg protein) x 103
72.1 ± 22.8
60.8 ± 28.7
0.49
RLU/(min/gram) x 105
24.4 ± 8.7
21.3 ± 9.9
0.61
Least square means are reported. Activity is reported in relative light units (RLU) per mg
of protein and per gram of tissue. Dam treatment is separated with standard errors for
each, and probability values (P-values) are indicated.
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CHAPTER V
CONCLUSION
Pregnancy status will differentially result in activity of CYP and UGT enzymes.
Endometrial biopsies collected from cattle throughout the estrous cycle only expressed
activity of UGT (Owen et al., Unpublished), as depicted in Figure 10. Activity of UGT
was localized in both intercaruncle and caruncle tissues of non-pregnant and pregnant
cattle that either failed to express or expressed estrus at d 16, with no differences
observed (P ≥ 0.05; Owen et al., Unpublished). In addition, activity of CYP1A and UGT
was localized in CL tissues of non-pregnant and pregnant cattle that either failed to
express or expressed estrus at d 16, with no differences observed (P ≥ 0.05; Owen et al.,
Unpublished) as depicted in Figure 10. In mid-gestation activity of CYP1A was localized
in cotyledonary tissue, caruncle tissue yielded activity of both CYP1A and CYP2C,
activity of CYP1A, CYP2C and UGT was found within CL tissue, activity of CYP1A
and UGT was found within fetal liver, and CYP1A, CYP2C, CYP3A, and UGT activity
was observed within maternal liver (Owen et al., Unpublished c). Finally, during late
gestation, activity of CYP1A, CYP3A, and UGT was observed within fetal liver, activity
of CYP1A and UGT was localized in cotyledonary tissue, and the caruncle tissue yielded
activity of CYP1A, CYP2C, and UGT. Based on these previous data, we can observe a
progression of enzyme activity in the reproductive tissues through gestation. Also, from d
85 to 240 of gestation activity of CYP1A and UGT increased in fetal liver and also
gained the activity of CYP3A from mid- to late gestation (Owen et al., Unpublished c).
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Figure 10

Activity of cytochrome P450 1A (CYP1A), cytochrome P450 2C (CYP2C),
cytochrome P450 3A (CYP3A), and uridine 5’diphosphateglucuronosyltransferase (UGT) in tissues collected from beef cattle during
the estrous cycle or gestation.

(A) Localization of UGT within endometrial tissues throughout the estrous cycle of
cattle. (B) Localization of enzymes within intercaruncle, caruncle, and corpora lutea
tissues at day 16 of non-pregnant and pregnant cattle. (C) Localization of enzymes within
maternal liver, fetal liver, corpora lutea, cotyledon, and caruncle tissues of day 85 of
gestation of cattle. (D) Localization of enzymes within fetal liver, cotyledon, and
caruncle tissues of day 240 of gestation of cattle. Activity of enzymes within the
endometrial tissues, including intercaruncle and caruncle tissues, are indicated in dark
blue. Activity of enzymes within the corpora lutea is indicated in green. Activity of
enzymes within the fetal liver is indicated in purple. Activity of enzymes within the
cotyledon tissue is indicated in maroon. Activity of enzymes within the maternal liver is
indicated in gray.
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EFFECTS OF BODY CONDITION SCORE (BCS) ON STEROID AND EICOSANOID
METABOLIZING ENZYME ACTIVITY IN VARIOUS MARE TISSUES DURING
WINTER ANESTROUS
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Abstract
The objective of the current study was to determine the activity of steroid and
eicosanoid metabolizing enzymes in horses with varying BCS. The BCS of twenty nonpregnant, anestrous mares were determined prior to euthanasia, and tissue samples were
collected from the liver, kidney, adrenal gland, ovary, and endometrium. Cytochrome
P450 1A (CYP1A), 2C (CYP2C), 3A (CYP3A), and uridine 5’-diphosphoglucuronosyltransferase (UGT) activities were determined using luminogenic substrates.
The MIXED procedure of SAS was used to test the effect of BCS on enzyme activity and
differences between tissues. Activity of CYP1A in adrenals was increased (p ≤ .05) in
BCS 5 versus BCS 4 and 6. Activity of CYP1A in liver was increased (p = .05) in BCS 4
versus BCS 5 and 6. Activity of CYP1A was 100-fold greater (p < .0001) in the liver than
in the adrenal, ovary, and kidney. Activity of CYP2C was 100-fold greater (p < .0001) in
the liver than in the adrenal, ovary, and endometrium. Activity of CYP3A was only
detectable in the liver. Activity of UGT in the kidney was decreased (p = .02) in BCS 4
versus BCS 5 and 6. Activity of UGT was 3-fold greater (p < .0001) in the liver than in
the kidney; whereas activity of UGT was 9-fold greater (p < .0001) in the kidney than in
the ovary and endometrium. In general, BCS did not alter the activity of steroid and
eicosanoid metabolizing enzymes in horses. However, tissue differences of these
enzymes indicated abundant hepatic metabolism in horses, which is similar to other
livestock species.

115

Introduction
Reproductive capabilities are dictated by the ability to maintain an adequate body
condition, as measured by body condition scores (BCS), indicating nutritional
maintenance has been met. However, excessive body condition, or amount of adipose
cover, can also cause reproductive failures in various livestock species. These
reproductive competencies can be heavily influenced by the production and metabolism
of hormones within the body that are vital throughout the estrous cycle and gestation.
Moderately conditioned, non-pregnant, cycling mares (approximate BCS of 5) yielded
greater serum concentrations of luteinizing hormone compared to fat conditioned
(approximate BCS of 7) mares (Cavinder, Vogelsang, Gibbs, Forrest, & Schmitz, 2007).
Serum progesterone and estradiol-17β concentrations in gestating ewes were greatest in
restricted fed ewes, whereas they were median in adequately fed ewes and lowest in
excessively fed ewes (Lemley et al., 2014). Both production and metabolism of steroid
hormones can be altered by nutritional status, which can alter BCS.
Steroid hormone metabolism occurs in two phases and have primarily been
identified in the liver of several species including humans (Kuehl, Lampe, Potter, &
Bigler, 2005), mice (Collier et al., 2012), cattle (Lemley, Wilmoth, Tager, Krause, &
Wilson, 2010), and sheep (Lemley et al., 2013). Post-menopausal women have expressed
uridine 5’-diphospho-glucuronosyltransferase (UGT) mRNA in endometrial tissues,
which indicates these metabolizing enzymes are still active through a reproductively
quiescent time (Duguay et al., 2004). Horses that were nutrient-restricted, which
resulted in low BCS (3 to 3.5) during the winter anestrous period, failed to ovulate or
form any type of luteal tissues; which was different as compared to mares that were
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maintained to a high BCS (7.5 to 8.5) that began recruiting follicles to ovulate normally
(Gentry et al., 2002). Pregnant cattle undergoing nutrient restriction had decreased
steroidogenic enzyme activity, cytochrome P450 (CYP) 1A and CYP2C, as well as an
increased concentration of estradiol (Hart, Camacho, Swanson, Vonnahme, & Lemley,
2014). No study had identified tissue distribution and relative activity of these enzymes
throughout the horse’s body. In addition, minimal information exists on the relationship
between steroidogenic enzyme activity and BCS in mares. Based on previous data in
other livestock species we hypothesized a concomitant increase in BCS and activity of
steroidogenic enzymes in mares. Therefore, the objective of the current study was to
determine the activity of steroid and eicosanoid metabolizing enzymes in horses with
varying BCS. In addition, we examined tissue distribution of steroid and eicosanoid
metabolizing enzymes in mares during winter anestrous.
Materials and Methods
Animal care and treatments
Animal care and use was conducted according to protocols approved by the
Mississippi State University Institutional Animal Care and Use Committee (study
#15093). Twenty non-pregnant mares were selected during the anestrous period of
January and ranged in age from 7 to 23 years. Due to these horses under the influence of
the winter anestrus period, peripheral hormone analysis was not conducted. Horses were
selected based on 3 primary criteria (geriatric status, lameness issues, and/or unsafe due
to behavioral attributes) and were allowed ad libitum access to water and native grass
pasture. Mares were separated into two groups: 1) 10 mares were maintained solely on
native grass pasture, and 2) 10 additional mares were supplemented with a commercial
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concentrate (Nutrena SafeChoice, Cargill, Inc., Minneapolis, MN) to achieve the desired
BCS for this study 4 (n = 6), 5 (n = 9), and 6 (n = 5), respectively. Approximately 20 hr
prior to administering euthanasia, horses were weighed and evaluated for a numerical
BCS (1-9), by two separate appraisers, based on the non-modified Henneke Body
Condition Scoring method (Henneke, Potter, & Kreider, 1984), with 1 being extremely
emaciated and 9 being extremely fat and obese. Horses were housed in a dry lot with ad
libitum access to water for approximately 10 hr prior to euthanasia.
Euthanasia, tissue collection, and processing
Horses were initially sedated with xylazine, at a dose of 1.1 mg/kg intravenously.
Once horses were under adequate sedation, ketamine was administered at a dose of 2.2
mg/kg intravenously to induce anesthesia. Potassium chloride solution was administered
intravenously, with an average volume of 750 mL, to cease cardiac function. Horses were
then exsanguinated by severing the carotid and jugular veins. After approximately 20 min
of exsanguination, horses were transported to the Mississippi State University School of
Veterinary Medicine Necropsy Laboratory where the exsanguinated weight was recorded.
Immediately after transportation, mares were eviscerated and organs were
removed from the general viscera, fat was detached, and organs were weighed. If the
organ was part of a pair, the pair of organs was weighed together (e.g. both kidneys).
Approximately 2 g of tissue was snap-frozen in liquid nitrogen and stored at -80°C. A
liver sample from the cranial portion of the right lobe on the diaphragmatic side was
collected which included the hepatic capsule. An adrenal gland sample was collected
from a single adrenal gland that was towards the central most portion and included the
adrenal capsule, adrenal medulla, and adrenal cortex. Kidney samples were collected
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from the lateral border of the right kidney, approximately 2 cm from the apex.
Endometrial samples were collected by opening the lumen of the uterus and collecting
the endometrial tissue directly adjacent (approximately 0.3 mm deep) to the lumen and
only in the left horn of the uterus. Ovaries were weighed and a portion of the left ovary
was sectioned, which had some antral follicle development. Approximately 100 mg of
tissue was placed into a polypropylene tube with 1 mL of potassium phosphate buffer
(400 mM, pH = 7.4). Samples were then mechanically homogenized using the Tissue
Tearor (Biospec Products, Bartlesville, OK, USA). Tissue homogenates were centrifuged
at 10,000 × g for 10 min at 4°C, and the supernatant was stored at −80°C until enzyme
assays were conducted. Protein concentration of the supernatant was determined by a
Coomassie Plus (Bradford) protein assay following the manufacturer’s protocol (Thermo
Scientific, Rockford, IL, USA).
Cytochrome P450 enzymes
Assay kits for CYP1A (P450-Glo CYP1A1 Assay) CYP3A (P450-Glo CYP3A4
Assay (Luciferin-IPA)), and CYP2C (P450-Glo CYP2C9 Assay) and NADPH
regeneration solution (NADPH Regeneration System) were purchased from Promega
Corporation (Madison, WI, USA) and assays conducted according to Hart et al. (2014)
with minor modifications. Briefly, reconstitution buffer was added to luciferin detection
reagent. Luciferin CEE (CYP1A), luciferin IPA (CYP3A), and luciferin H (CYP2C) were
diluted in KPO4 buffer. Tissue homogenates (30 µg of protein per well) and enzymespecific luciferin substrate were added to 96-well opaque white plates in duplicate. Plates
were then pre-incubated for 10 min (CYP1A), 30 min (CYP3A), or 90 min (CYP2C) at
37°C. Following the incubation, NADPH regeneration solution was added to each well
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and plates were incubated for 30 min (CYP1A and CYP2C) at 37°C or 10 min (CYP3A)
at room temperature. After the incubation, luciferin detection reagent was added to each
well and plates were protected from light and incubated for an additional 20 min at room
temperature. Plates were then placed into a Promega Multi-Plus plate reader (Promega
Corporation, Madison, WI, USA) and luminescence was measured. A linear relationship
was determined between the rate of luminescence in relative light units (RLU) versus the
concentration of protein from the various tissues.
Uridine 5’-diphospho-glucuronosyltransferase (UGT)
The UGT assay kit was purchased from Promega Corporation (Madison, WI,
USA) and the assay performed according to Hart et al. (2014) with minor modifications.
Briefly, uridine diphosphoglucoronic acid (UDPGA) was added to half of the wells of a
96-well opaque white plate to act as reaction wells, and nuclease-free water was added to
the remaining wells to act as control wells. The UGT reaction mixture containing UGT
multienzyme substrate was then combined with tissue homogenates (28 µg of protein per
well), and the plates were preincubated for 90 min at 37°C. After incubation, detection
reagent was added to each of the wells followed by an incubation period of 20 min at
room temperature while being protected from light. The plates were then analyzed using
a Promega Multi- Plus plate reader with luminescence detection mode. Activity of UGT
was calculated by following the manufacturer’s recommended formulas.
Statistical analysis
The MIXED procedure of SAS (SAS Inst. Inc, Cary, NC, USA) was used to test
the effect of BCS within a given tissue as well as enzyme activity of these between
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tissues. Live body weight, age, and group were also in the model as covariates and only
removed if they did not yield a p-value of ≤ .20. Data found to be nonnormally
distributed were tested using the Wilcoxon rank sum test. Treatment means were
separated using the PDIFF options of the LSMEANS statement. Least square means and
standard error of the mean are reported. Statistical significance was declared at p ≤ .05.
Results
Effect of body and tissue weights and tissue activity
Final live body weight, exsanguinated, eviscerated, and organ weights are
displayed in Table 1. No differences were observed across BCS in live body,
exsanguinated, eviscerated, liver, adrenal, kidney, reproductive tract, and ovary weights.
Activity of enzymes (RLU/mg of protein) among tissues are displayed in Figure 1.
Activity of CYP1A, CYP2C, and UGT were greatest in hepatic tissues (p < .0001)
compared to extra-hepatic tissues. Activity of CYP1A was 100-fold greater (p < .0001) in
the liver than in the adrenal, ovary, and kidney; whereas activity of CYP1A was
undetectable in the endometrium (Figure 1A). Activity of CYP2C was 100-fold greater (p
< .0001) in the liver than in the adrenal, ovary, and endometrium; whereas activity of
CYP2C was undetectable in the kidney (Figure 1B). Activity of CYP3A was only
detectable in the liver (Figure 1C). Activity of UGT was 3-fold greater (p < .0001) in the
liver than in the kidney; whereas activity of UGT was 9-fold greater (p < .0001) in the
kidney than in the ovary and endometrium (Figure 1D). Similar results were observed
when enzyme activity was expressed relative to gram of tissue or total tissue weight (data
not shown).
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Effect of body condition score
Activity of CYP1A, per mg of protein, were not different (p = .06) among BCS
within liver tissue (Table 2). However, activity of CYP1A (RLU/g of tissue) was
different (p = .05) among BCS within liver tissue, where horses with BCS 4 was
increased (p = .02) compared to horses with BCS 5 (Table 2). Total liver activity of
CYP1A was not different (p = .20) among BCS (Table 2). Activity of CYP2C, CYP3A,
and UGT were not different (p ≥ .41) among BCS within liver tissue (Table 2).
Activity of CYP1A, relative to mg of protein, per gram of tissue, and total activity
of the adrenal gland, were different (p ≤ .02) among BCS, where horses with BCS 5 were
increased compared to horses with BCS 4 and 6, respectively (Table 3). Activity of
CYP2C was not different (p ≥ .71) among BCS within adrenal tissue (Table 3). Activity
of CYP1A was not different (p ≥ .32) among BCS within kidney tissue (Table 3).
Activity of UGT, relative to mg of protein and per gram of tissue, was different (p ≤ .02)
among horses with BCS within kidney tissue, where horses with BCS 4 were decreased
(p = .005) compared to horses with BCS 5, but horses with BCS 4 were not different (p ≥
.10) compared to horses with BCS 6 (Table 3). However, total activity of UGT in the
kidney was not different (p = .36) among BCS (Table 3). Mare BCS did not alter activity
of CYP1A, CYP2C, or UGT within ovarian tissue (Table 4). Similarly, mare BCS did not
alter activity of CYP2C or UGT within endometrial tissue (Table 4).
Discussion
Enzyme activity was greatest in hepatic tissues (p < .0001), which reflects the
results of several other studies conducted with monkeys (Uno, Fujino, Kito, Kamataki, &
Nagata, 2006), mice (DeLozier et al., 2004), and sheep (Dupuy, Larrieu, Braun,
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Alvinerie, & Galtier, 2001). This is due to the liver acting as the primary organ of
metabolism within the body. In addition, there is a differential effect of species on the
extent of the enzyme activity between organs, which is evident through the exponentially
greater CYP1A activity in cattle as compared to pigs, goats, and sheep (Hart et al., 2014).
Hepatic CYP1A activity (per gram of tissue) from the mare’s in this experiment was
increased 20-fold as compared to cattle, and these horses have 150-fold greater hepatic
CYP1A activity as compared to ewes (Kennedy et al., 2016; Lekatz et al., 2015). Horse
hepatic CYP2C activity (per mg of protein) from this study was increased 6100-fold as
compared to cattle and was increased 3.5-fold as compared to sheep (Kennedy et al.,
2016; Lekatz et al., 2015). Horse hepatic CYP3A activity (per mg of protein) from this
study have 2100-fold greater activity than that of cattle, but have 1.5-fold lesser activity
than that of sheep (Kennedy et al., 2016; Lekatz et al., 2015). Horse hepatic UGT activity
(per mg of protein) from this study was increased 4.3-fold and 3.6-fold as compared to
cattle and sheep (Kennedy et al., 2016; Lekatz et al., 2015), respectively.
The enzyme activity within the liver of cattle is supported by greatest mRNA
expression of specific isoforms of the three enzymes, CYP1A2, CYP2C9, and CYP3A4
in hepatic tissues (Darwish, Ikenaka, El-Ghareeb, & Ishizuka, 2010). However, CYP1A1,
an isoform of CYP1A, yielded greatest mRNA expression within the kidney of cattle
(Darwish et al., 2010), which could explain the greatest extra-hepatic activity of CYP1A
in the kidney tissue from the mares in the current study. Expression of mRNA of these
steroid metabolizing enzymes is highly species-dependent, which is evident through the
differential expression of isoforms of CYP1A and UGT in hepatic tissues between sheep
and cattle (Girolami et al., 2016). In cattle, Darwish et al. (2010) showed the greatest
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expression of UGT1A1 mRNA within the kidney followed by hepatic tissues. In contrast,
the current study found that UGT enzyme activity in horses were greatest in hepatic
tissue followed by the kidney. However, of the 5 horse tissues examined, only hepatic
tissue expressed CYP3A activity. Cultured bovine endometrial cells had an 1800-fold
increase in CYP2C activity as compared to the endometrial samples from the horses in
the current study (Gilfeather & Lemley, 2016). Conversely, endometrial activity of
CYP2C from bovine endometrial biopsies had no detectable activity of CYP2C, which is
similar to the current results in the horse (Owen and Lemley, unpublished data). The
horse endometrium exhibited activity of UGT, whereas the cultured bovine endometrial
cells did not express UGT activity (Gilfeather & Lemley, 2016). Ovarian tissue from the
current study did not express differences in CYP1A, CYP2C, or UGT between BCS,
which is probably due to the reproductive status of the mares, winter anestrous, at the
time of harvest.
The primary steroid that CYP1A metabolizes is estrogen, which should not have
been in large quantities due to the quiescence of the ovaries under winter anestrous. In
addition to steroids, cytochrome P450 enzymes metabolize several eicosanoids. This
eicosanoid metabolism could explain the BCS differences seen in the adrenal gland
across all indices of CYP1A. However, this does not explain the lack of differences
expressed in CYP2C indices. More research is needed to elucidate the mechanisms of
CYP1A within the adrenal gland. While the horses utilized in the current study were all
stock type horses, there were various breeds including quarter horse, paint, and
thoroughbred. Ewes that were given 60%, 80%, and 100% of their metabolizable protein
between days 90 and 130 of gestation did not have different liver weights (p = .66),
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which was reflected by no differences in final body weight (Lekatz et al., 2015). This
differential expression and activity of these steroid and eicosanoid enzymes between
species and breeds could explain the results of the enzyme activity of these horse tissues.
Restricted feeding regimes during gestation in cattle significantly decreased the
activity of CYP1A and CYP2C in the liver (Hart et al., 2014), which does not match up
with the current data set, as horses with BCS 4 yielded the greatest activity of CYP1A
when compared to horses with BCS 5 (ideal), while horses with BCS 6 were
intermediate. However, these tissues were collected during the winter anestrous period,
which was verified by a lack of luteal structures on the ovaries; therefore, these horses
were not under the influence of progestins. Moreover, during this winter anestrous
period, mares grow small cohorts of follicles which will not produce large amounts of
estrogens, which are metabolized by and upregulate CYP1A. The adrenal gland produces
steroids in the body, which could also explain the differences seen between mare BCS
with regards to the CYP1A activity within the adrenal gland. Metabolism of steroids and
eicosanoids is done to inactivate and increase the polarity for the molecules in order to
excrete them from the body. One method of excretion is through the urine which is
filtered and excreted to the bladder via the kidney. Differences in the activity of UGT
could be due to the varying amount of phase II metabolism between BCS of the mares in
this study. Greater feed intake not only increases liver blood flow but also increases
steroid metabolism in lactating and non-lactating dairy cattle (Sangsritavong, Combs,
Sartori, Armentano, & Wiltbank, 2002; Vonnahme et al., 2013). Horses are a unique
livestock species due to their additional dependence on 5α-dihydroprogesterone as a vital
progestin, different from other livestock species relying solely on progesterone (Scholtz
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et al., 2014). Ovariectomized mares treated with sub-physiological 5αdihydroprogesterone resulted in glandular development that mirrored mares under a
normal luteal cycle (Scholtz et al., 2014), which indicates that 5α-dihydroprogesterone is
required for adequate glandular development to prepare for impending gestation.
Reduced BCS by chronic feed restriction significantly decreases peripheral
concentrations of progesterone (Gentry et al., 2002). Activity of CYP1A expressed as mg
of protein, per gram of tissue, and total activity were lowest (p < .01) in ewes fed 60% of
their metabolizable protein as compared with ewes fed 80 and 100% (Lekatz et al., 2015).
These data support previous research that horses metabolize hormones in the
liver, similar to other species (Dupuy, Larrieu, Braun, Alvinerie, & Galtier, 2001;
DeLozier et al., 2004; Uno, Fujino, Kito, Kamataki, & Nagata, 2006). Also, these data
can be used to further examine the enzyme profile for use in xenobiotic metabolism,
which is also performed by the CYP and UGT enzymes. This could assist in the
knowledge about the clearance of anti-inflammatory medications, such as
Dexamethasone, from extra-hepatic tissues. This extra-hepatic metaboolism is
influenced, in some tissues, by BCS of horses and could provide information for dosages
based not only on weight, but BCS as well. Finally, these data could help better
understand the metabolic impact that BCS can have on the body of horses that can
influences the endocrine profiles.
Conclusion
Activity of steroid and eicosanoid metabolizing enzymes does not provide an
implication of BCS effects in horses. A wider range of horse BCS might provide a greater
amount of diversity to detect BCS influences on hormone metabolizing enzyme activity.
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This is supported by the lack of differences observed in exsanguinated and eviscerated
weights. Tissue differences of these enzymes indicated abundant hepatic metabolism
followed by renal metabolic activity in horses. Finally, horses that are not in winter
anestrous may yield different results because of the nature of steroid metabolizing
enzymes.
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Figure 11

Activity of cytochrome P450 1A (CYP1A; A), 2C (CYP2C; B), 3A
(CYP3A; C), and uridine 5’diphospho glucuronosyltransferase (UGT; D)
across different horse tissues. ND indicates that no activity was detected.

Least square means with different letters represent significant differences (p ≤ .05).
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Table 8

Measurements of several body and organ weights in horses across body
condition score (BCS) 4, 5, and 6. Data are reported as the mean ± standard
error.
BCS
5

Dependent variable
4
6
p-Value
Live body weight,
443 ± 21
455 ± 11
493 ± 12
.10
kg†
Exsanguinated body
392 ± 18
406 ± 10
444 ± 12
.53
weight, kg‡
Eviscerated body
287 ± 11
318 ± 21
312 ± 11
.39
weight, kg§
Liver weight, kg
4.9 ± 0.9
5.0 ± 0.6
4.3 ± 0.4
.74
Adrenal weight, g
30.5 ± 5.1
35.8 ± 3.3
28.4 ± 2.6
.18
Kidney weight, kg
1.8 ± 0.4
1.6 ± 0.1
1.6 ± 0.2
.88
Reproductive tract
weight, kg¶
1.5 ± 0.2
1.3 ± 0.1
1.5 ± 0.2
.42
Ovary weight, g
31.9 ± 5.1
39.3 ± 4.9
49.1 ± 12.3
.57
p-values for the main effect of BCS are reported. Least square means with different
letters represent significant differences (p < .05). †Live body weight was obtained 24 hr
prior to anesthesia and euthanasia via exsanguination. ‡Exsanguinated weight = live body
weight – blood volume. §Eviscerated weight = exsanguinated weight – (internal organ
weight + hide weight + front leg weight + mane weight + tail weight). ¶Reproductive tract
weight = mare reproductive tract (ovaries + oviduct + uterus + cervix + vagina) +
bladder.
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Table 9

Activity of cytochrome P450 1A (CYP1A), cytochrome P450 2C (CYP2C),
cytochrome P450 3A (CYP3A), and uridine 5’diphosphateglucuronosyltransferase (UGT) in horse liver tissue. Activity is reported in
relative light units (RLU) per mg of protein, per gram of tissue, and total
tissue activity ± standard error.
BCS
5

Dependent variable
4
6
p-Value
LIVER
CYP1A
RLU/(min*mg
72.1 ± 8.4
48.4 ± 6.6
53.1 ± 8.0
.06
protein)x103
RLU/(min/gram)
28.0 ± 2.9a
18.4 ± 2.4b
20.1 ± 2.8ab
.05
5
x10
RLU/(min*liver)
131.7 ± 18.7
95.7 ± 20.4
85.7 ± 13.2
.20
x108
CYP2C
RLU/(min*mg
15.8 ± 7.7
24.7 ± 6.4
15.0 ± 4.3
.71
protein)x103
RLU/(min/gram)
75.5 ± 38.3
174.0 ± 58.1
75.8 ± 28.0
.41
x104
RLU/(min*liver)
7.2 ± 1.9
54.9 ± 27.6
22.0 ± 11.8
.43
8
x10
CYP3A
RLU/(min*mg
13.6 ± 2.2
11.0 ± 1.1
11.5 ± 1.2
.75
protein)x105
RLU/(min/gram)
53.1 ± 7.9
41.9 ± 4.3
43.9 ± 5.4
.49
6
x10
RLU/(min*liver)
22.7 ± 3.6
19.0 ± 1.7
18.2 ± 2.5
.61
10
x10
UGT
RLU/(min*mg
21.7 ± 3.2
25.2 ± 2.6
23.5 ± 4.5
.58
protein)x105
RLU/(min/gram)
85.3 ± 13.8
96.6 ± 10.6
90.9 ± 18.9
.78
x106
RLU/(min*liver)
41.6 ± 8.9
43.5 ± 3.0
39.4 ± 9.3
.85
x1010
p-values for the main effect of BCS are reported. Least square means with different
letters represent significant differences (p < .05).
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Table 10

Activity of cytochrome P450 1A (CYP1A) and cytochrome P450 2C
(CYP2C) in adrenal tissue. Activity of CYP1A and uridine 5’diphosphateglucuronosyltransferase (UGT) in kidney tissue. Activity is reported in
relative light units (RLU) per mg of protein, per gram of tissue, and total
tissue activity ± standard error.
BCS
5

Dependent variable
4
6
p-Value
ADRENAL GLAND
CYP1A
RLU/(min*mg
279 ± 99.2a
897 ± 152.7b
300 ± 109.4a
.02
protein)
RLU/(min/gram)
10.3 ± 3.6a
36.1 ± 7.2b
11.1 ± 4.1a
.01
3
x10
RLU/(min*adren
26.9 ± 10.7a
109.5 ± 22.3b
28.3 ± 8.6a
.01
al) x104
CYP2C
RLU/(min*mg
206 ± 72
136 ± 62
164 ± 58
.71
protein)
RLU/(min/gram)
65.1 ± 21.1
45.1 ± 18.5
53.2 ± 18.8
.74
2
x10
RLU/(min*adren
18.1 ± 5.9
16.3 ± 7.1
16.2 ± 6.6
.82
4
al) x10
KIDNEY
CYP1A
RLU/(min*mg
104 ± 35.9
236 ± 141.2
41.9 ± 21.6
.53
protein)
RLU/(min/gram)
38.6 ± 13.9
93.7 ± 58.3
14.6 ± 8.2
.64
2
x10
RLU/(min*kidne
47.1 ± 14.4
107.9 ± 60.1
23.8 ± 15.6
.32
y) x105
UGT
RLU/(min*mg
56.8 ± 6.7a
81.9 ± 4.7b
91.4 ± 14.7b
.02
4
protein)x10
RLU/(min/gram)
21.5 ± 2.4a
32.2 ± 2.0b
34.9 ± 5.8b
.01
6
x10
RLU/(min*kidne
36.7 ± 7.0
51.8 ± 5.6
54.8 ± 7.5
.36
y) x109
p-values for the main effect of BCS are reported. Least square means with different
letters represent significant differences (p < .05).
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Table 11

Activity of cytochrome P450 1A (CYP1A), cytochrome P450 2C (CYP2C),
cytochrome P450 3A (CYP3A), and uridine 5’diphosphateglucuronosyltransferase (UGT) in mare reproductive tissues. Activity is
reported in relative light units (RLU) per mg of protein, per gram of tissue,
and total tissue activity ± standard error.
BCS
5

Dependent variable
4
OVARY
CYP1A
RLU/(min*mg
protein)x102
14.0 ± 0.8
7.0 ± 3.2
RLU/(min/gram)
x103
41.1 ± 5.6
25.3 ± 10.6
RLU/(min*ovary)
x104
166 ± 79.4
123 ± 67.6
CYP2C
RLU/(min*mg
385 ± 112
326 ± 137
protein)
RLU/(min/gram)
10.9 ± 4.2
11.0 ± 4.8
3
x10
RLU/(min*ovary)
41.6 ± 24.0
36.9 ± 14.3
4
x10
UGT
RLU/(min*mg
protein)x104
14.6 ± 4.8
10.1 ± 1.5
RLU/(min/gram)
x105
30.0 ± 4.3
35.2 ± 5.9
RLU/(min*ovary)
x107
10.3 ± 2.8
14.3 ± 3.5
ENDOMETRIUM
CYP2C
RLU/(min*mg
156 ± 28
169 ± 25
protein)
RLU/(min/gram)
54.3 ± 8.7
60.3 ± 8.3
x102
UGT
RLU/(min*mg
protein)x103
82.6 ± 16.8
108.4 ± 16.5
RLU/(min/gram)
x105
30.5 ± 6.0
36.9 ± 3.1
p-values for the main effect of BCS are reported.
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6

p-Value

1.9 ± 1.2

.84

7.0 ± 5.1

.55

28 ± 19.0

.27

187 ± 36
6.0 ± 1.2
28.0 ± 7.0

.33
.74
.86

9.7 ± 2.5

.94

33.0 ± 7.9

.97

12.2 ± 2.2

.82

120 ± 34
36.5 ± 9.0

.73
.36

81.4 ± 18.8

.68

29.3 ± 6.5

.65
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